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Re sume  
La borréliose de Lyme est une zoonose transmise par les tiques. Les bactéries qui en 
sont la cause, des spirochètes, se trouvent principalement chez des hôtes réservoirs sauvages 
tels que des rongeurs ou des petits oiseaux terrricoles. Borrelia afzelii est l’un des pathogènes 
responsables de la borréliose de Lyme les plus importants en Europe et est transmis par la 
tique du mouton Ixodes ricinus. Pendant le repas sanguin de la tique, le pathogène peut 
infecter l’hôte. La bactérie change l’expression des protéines de surfaces externes (Osp) 
pendant l’infection pour pouvoir s’adapter efficacement à l’hôte ou à la tique. L’une de ces 
protéines, OspC, joue un rôle important dans le développement de l’infection chez l’hôte. 
Pendant le développement de l’infection systémique dans l’hôte vertébré, ce dernier va 
développer une immunité acquise (ex : anticorps) contre diverses protéines des spirochètes 
incluant OspC. Une des stratégies développée par le pathogène pour contourner les anticorps 
anti-OspC d’un hôte déjà infecté par une autre souche de Borrelia est de porter un allèle 
différent pour ospC. Nous pouvons ainsi distinguer des souches de B. afzelii en fonction de 
l’ospC dont elles disposent.  
Borrelia afzelii dispose de deux modes de transmission: la transmission systémique 
(de l’hôte à la tique) et la transmission par co-feeding (de la tique à la tique). La transmission 
systémique requiert le développement d’une infection très répandue, multi-systémique, dans 
l’hôte vertébré dans le but de faciliter la transmission à de nouvelles tiques. Pendant la 
transmission par co-feeding, l’hôte crée simplement un pont qui va amener la tique infectée et 
la tique non-infectée à proximité l’une de l’autre. La transmission par co-feeding peut ainsi 
être une stratégie pour les spirochètes d’éviter le système immunitaire acquis et d’infecter de 
nouvelles tiques naïves. 
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Pour tester cette hypothèse, nous avons immunisé des souris de laboratoire avec l’une 
des deux protéines recombinantes OspC (rOspC) qui correspondent à deux souches 
différentes de B. afzelii : A3 et A10. Les anticorps contre un antigène OspC particulier 
bloquent la souche ciblée (homologue) mais pas la souche non-ciblée (hétérologue). 
L’immunisation réduit aussi drastiquement l’efficacité de la transmission par co-feeding. 
Chez les souris non-immunisées (contrôles) et les homologues, la transmission par co-feeding 
a atteint une prévalence de 51,6 % tandis que pour les souris homologues, ce taux n’a atteint 
que 3.3 %, correspondant à une baisse de 15,6 fois. 
Nous avons recherché les effets de l’immunité acquise croisée en comparant les 
phénotypes d’infection entre les hétérologues et les souris contrôles. Les souris hétérologues 
ont une première expérience avec le ‘mauvais’ antigène OspC, et ces souris sont donc 
suspectées de répondre plus efficacement à l’infection avec B. afzelii que les souris contrôles 
naïves. Nous avons trouvé que l’immunité croisée avait un effet sur la charge en spirochètes 
des nymphes qui se sont nourries à l’état de larve sur les souris 1 mois après l’infection. La 
charge en spirochète moyenne dans les nymphes était 2,1 fois plus haute dans le groupe 
contrôle que dans le groupe hétérologue. 
Il y avait aussi un grand effet du mode de transmission sur la charge en spirochètes des 
nymphes. La charge en spirochètes était en moyenne 4 fois plus basse dans les tiques de co-
feeding  que dans les tiques infectées par transmission systémique. Finalement, nous avons vu 
un effet important du vieillissement de la tique sur la charge en spirochètes des nymphes. Les 
nymphes qui ont été tuées 4 mois après la mue de la larve à la nymphe avaient une charge en 
spirochètes qui étaient 6,3 à 15,3 fois plus basse que les nymphes qui ont été tuées 3 mois plus 
tôt. Cette baisse de la charge en spirochètes à mesure que l’infection vieillit dans la nymphe  
pourrait avoir un effet sur la fitness de B. afzelii. 
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Cette thèse de doctorat a démontré que la transmission par co-feeding ne permet pas à 
B. afzelii d’échapper aux anticorps spécifiques anti-OspC et que la réponse immunitaire de 
l’hôte avait un effet négatif sur la fitness de Borrelia. Ce travail fournit de nouvelles 
informations sur les mécanismes de la transmission par co-feeding, sur les interactions hôte-
parasite d’un pathogène responsable de la maladie de Lyme, et sur les effets de l’immunité 
acquise d’un hôte vertébré sur la transmission du pathogène. 
 
Mots clés : Borrelia afzelii ; co-feeding ; immunité acquise ; transmission systémique ; 
OspC ; Ixodes ricinus. 
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Abstrâct 
Lyme borreliosis is a tick-borne zoonotic disease and the causative spirochete bacteria 
are predominantly found in wildlife reservoirs such as rodents and ground-dwelling birds. 
Borrelia afzelii is one of the most common Lyme borreliosis pathogens in Europe, and is 
transmitted by the sheep tick Ixodes ricinus. During the tick blood meal, the pathogen can 
infect the host. The bacteria change the expression of their outer surface proteins (Osp) during 
the infection to adapt efficiently to the vertebrate host or the tick vector. One of these 
proteins, OspC, plays an important role in the development of host infection. 
The systemically infected vertebrate host develops an acquired immune response (e.g. 
antibodies) against various spirochete proteins including OspC. One of the strategies 
developed by the pathogen to avoid the OspC-specific antibodies of a host already infected by 
a given Borrelia strain is to carry a different ospC allele. The ospC gene is therefore a useful 
genetic marker for classifying B. afzelii into different strains. 
Borrelia afzelii has two modes of transmission: systemic (host-to-tick) transmission 
and co-feeding (tick-to-tick) transmission. Systemic transmission requires the development of 
a widespread, multi-system infection in the vertebrate host to facilitate transmission to new 
vector ticks. During co-feeding transmission, the host merely forms the bridge that brings the 
infected and uninfected ticks in close proximity to each other. Co-feeding transmission could 
therefore be a strategy for the spirochete to avoid the host immune system and to infect new 
naïve ticks.  
To test this hypothesis, we immunized lab mice with one of two recombinant OspC 
(rOspC) proteins that belonged to two different strains of B. afzelii: A3 and A10. Antibodies 
against a particular OspC antigen blocked infection of the targeted (homologous) strain but 
not the non-targeted (heterologous) strain. Immunization also drastically reduced the efficacy 
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of co-feeding transmission. In non-immunized or heterologous mice, the co-feeding 
transmission rate was 51.6 % whereas in homologous mice, this rate was 3.3%, corresponding 
to a 15.6-fold decrease. 
We investigated the effects of cross-reactive acquired immunity by comparing the 
infection phenotypes between heterologous and control mice. The heterologous mice had 
previous experience with the heterologous OspC antigen, and we therefore predicted that 
these mice would respond more efficiently to infection with B. afzelii than the completely 
naive control mice. We found that cross-immunity had an effect on the spirochete load in the 
nymphal ticks that had fed on the mice one month post-infection. The mean nymphal 
spirochete load was 2.1 times higher in the control group than in the heterologous group. 
There was also a large effect of the mode of transmission on the nymphal spirochete 
load. The spirochete load was on average 6 times lower in co-feeding ticks than in ticks 
infected via systemic transmission. Finally, there was an important effect of nymphal ageing 
on the spirochete load inside the nymph. Nymphs that were examined four months after the 
larva-to-nymph molt had a spirochete load that was 6.3 to 15.3 times lower than nymphs that 
were examined 3 months earlier. This decrease in spirochete load as the infection ages inside 
the nymphal tick could have an effect on the fitness of B. afzelii. 
This PhD thesis demonstrated that co-feeding transmission does not allow B. afzelii to 
escape the OspC-specific antibodies and that host acquired immunity had a negative effect on 
the fitness of Borrelia spirochetes. This work provides new information on the mechanism of 
co-feeding transmission, on the host-parasite interactions of an important Lyme disease 
pathogen, and on the effect of acquired immunity in the vertebrate host on pathogen 
transmission. 
Keywords: Borrelia afzelii ; co-feeding ; acquired immunity ; systemic transmission ; OspC ; 
Ixodes ricinus. 
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1. Introduction 
1.1. General background: 
1.1.1. History of Lyme disease: 
Lyme borreliosis or Lyme disease is the most common vector-borne disease in the 
Northern hemisphere. This tick-borne disease was discovered by the physician Allen C. 
Steere in 1972 in the city of Old Lyme (hence the name Lyme disease), in Connecticut, USA 
(Steere et al., 1977). A number of children and adults had been diagnosed with arthritis and a 
link was made with the clinical symptoms that follow a tick bite. In 1982, William Burgdorfer 
isolated the first spirochetes from the deer tick Ixodes scapularis (Burgdorfer et al., 1982). In 
1984, after the isolation of spirochetes from the blood of patients (Benach and Coleman, 
1987) and the discovery of spirochetes in the sheep tick Ixodes ricinus in Europe (Burgdorfer 
and Keirans, 1983), the spirochete was named Borrelia burgdorferi (Hyde and Johnson, 1984) 
in honor of its discoverer, William Burgdorfer.  
1.1.2. The tick-borne pathogen Borrelia burgdorferi sensu lato: 
Borrelia burgdorferi sensu lato (s. l.) forms a genospecies complex that includes 12 
described genospecies. In Europe, the three main genospecies that cause Lyme disease are B. 
burgdorferi sensu stricto (the only species that infects humans in North America), B. afzelii 
and B. garinii (Baranton et al., 1992; Wang et al., 1999a; Rudenko et al., 2011). The different 
genospecies of the Borrelia burgdorferi s. l. genospecies complex are specialized on different 
vertebrate hosts (Kurtenbach et al., 2002). For example, Borrelia afzelii and Borrelia garinii 
are specialized on rodents and birds, respectively (Kurtenbach et al., 1998b; Humair et al., 
1999; Kurtenbach et al., 2002; Hanincova et al., 2003a; Hanincova et al., 2003b). This host 
specificity appears to be mediated by the tolerance of the pathogen to the complement system 
of the vertebrate host (Kurtenbach et al., 1998a). Some vertebrate hosts such as roe deer and 
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sheep appear to be completely resistant to infection with B. burgdorferi s. l. pathogens 
(Jaenson and Talleklint, 1992; Ogden et al., 1997). 
 
1.1.3. Diagnosis and treatment of Lyme disease in humans 
The diversity of B. burgdorferi s. l. genospecies that cause Lyme disease in humans leads 
to a variety of clinical manifestations (van Dam et al., 1993). Some of the typical 
manifestations of the early stage of the infection are the erythema migrans skin lesion, Lyme 
neuroborreliosis, and Lyme carditis (Stanek et al., 2012). The late stage of the disease 
includes symptoms such as arthritis, skin disorders, and neurological problems (Stanek et al., 
2012). One of the difficulties with diagnosing Lyme disease is the number of clinical 
manifestations that can be confused with other diseases, leading sometimes to the wrong 
diagnosis. Detection of pathogen exposure depends on serological tests such as the enzyme 
linked immuno-sorbent assay (ELISA) or by western blot (Stanek et al., 2012). In the 
laboratory, ELISA, polymerase chain reaction (PCR), and quantitative PCR (qPCR) can be 
used to detect B. burgdorferi s. l. in vertebrate hosts or ticks. If the disease is diagnosed early, 
a three-week antibiotic treatment (e.g. doxycycline) usually cures the infection (Stanek et al., 
2012). 
1.1.4. The life cycle of Ixodes ticks: 
Borrelia burgdorferi s. l. pathogens are transmitted by ticks of the Ixodes species complex, 
which include I. ricinus in Europe, I. persulcatus in Eurasia, I. scapularis in eastern North 
America, and I. pacificus in western North America (Steere and Malawista, 1979; Piesman 
and Gern, 2004; Gern, 2009; Mannelli et al., 2011). The sheep tick Ixodes ricinus belongs to 
the class Arachnida (spiders, scorpions, ticks, and mites), the order Ixodida, the family of 
Ixodidae (hard ticks), and finally the genus of Ixodes.  
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The life cycle of Ixodes ticks has four stages: the egg, the larva, the nymph and the adult. 
The larvae, nymphs, and adult female ticks require a single blood meal from a vertebrate host 
to develop into the next stage (Wall and Shearer, 1997). Ixodes ticks engage in questing 
behavior to find a host, which consists of climbing up the vegetation (e.g., grass) and waiting 
for a passing host (Gigon, 1985). While questing, the tick’s front-legs are stretched out to grab 
fur, feathers, or clothes depending on the type of host. Ticks are very sensitive to dehydration 
and must frequently return to the humid leaf litter in order to rehydrate (Gigon, 1985). Ticks 
are ectotherms and are therefore also sensitive to changes in temperature. For this reason, tick 
questing activity peaks in spring and late summer when the temperature and the relative 
humidity are suitable (Figure 1) (Kurtenbach et al., 2006).  
After grabbing a host, the tick searches for an appropriate place to attach and take a blood 
meal. Ticks are often aggregated on the heads of rodents or birds, as this area is more difficult 
to groom (Randolph, 1975; Craine et al., 1995; Schmidt et al., 1999). This aggregation 
behavior can facilitate co-feeding transmission of tick-borne pathogens (see point 1.1.6.). The 
blood meal lasts around 3 days for larvae, 5 days for nymphs and 7 days for adult females 
(Gigon, 1985). After obtaining a full blood meal, the ticks drop off their host and reside on or 
near the soil surface, where they need a minimum relative humidity of 80% to survive (Gigon, 
1985). Depending on the stage and the environmental conditions, development into the next 
stage can take from 4 weeks to several months. Adult female ticks die after laying a single 
clutch of eggs that contains as many as 2,000 offspring. The tick life cycle can last between 2 
to 6 years depending on the environmental conditions (Gigon, 1985). 
The life stages prefer different species of vertebrate host. The larvae are mainly found on 
small rodents and ground-dwelling birds but can also feed on larger mammals. Nymphs are 
also found on small mammals and birds but prefer to feed on larger mammals such as roe deer 
(Matuschka et al., 1991). Finally, adult ticks are found only on large mammals. 
Introduction 
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Figure 1: The relative host-seeking activity depends on the season for the three stages (larva, 
nymph, and adult) of the two main tick vectors of B. burgdorferi sensu lato: I. scapularis in 
the northeastern United States and I. ricinus in Central Europe, northern England and 
Scotland (Kurtenbach et al., 2006). 
1.1.5. The life cycle of Lyme disease pathogens: 
Lyme borreliosis is a zoonotic tick-borne disease that is maintained in nature by 
transmission cycles involving immature larval ticks and competent vertebrate reservoir hosts 
(Barbour and Hayes, 1986). Larval ticks acquire the spirochetes after taking a blood meal 
from an infected vertebrate host. The blood-engorged larva molts into a nymph and maintains 
the infection via transstadial transmission (Nadelman and Wormser, 1998). The following 
year the infected nymph can transmit the pathogen to a competent reservoir host during its 
next blood meal. Adult ticks can acquire B. burgdorferi s. l. pathogens during the larval or 
nymphal blood meal (Barbour and Hayes, 1986; Nadelman and Wormser, 1998). Adult ticks 
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do not make a direct contribution to the maintenance of B. burgdorferi s. l. pathogens because 
they mainly feed on incompetent vertebrate hosts such as deer (Figure 2) (Telford et al., 1988; 
Jaenson and Talleklint, 1992). However, adult ticks can transmit Lyme disease pathogens to 
humans. There is no transovarial transmission of B. burgdorferi s. l. pathogens from infected 
female adult ticks to their offspring (Rollend et al., 2013). 
 
 
Figure 2: Enzootic cycle of Borrelia burgdorferi sensu lato (Brisson et al., 2012). 
1.1.6. Systemic and co-feeding transmission: 
Many tick-borne pathogens have two distinct modes of transmission: systemic 
transmission and co-feeding transmission. Systemic transmission requires the development of 
a systemic infection inside the vertebrate competent host. After the bite of an infected tick, the 
host (e.g. a rodent) develops a systemic infection within two to three weeks (Donahue et al., 
Introduction 
12 
1987). The host is now infectious and can transmit the spirochete to feeding ticks. The 
problem with systemic transmission is that there is a temporal delay while the infection 
becomes patent inside the vertebrate host during which transmission is not possible.  
This temporal delay is avoided by co-feeding transmission, which has been reported in a 
number of tick-borne pathogens including Borrelia afzelii (Gern and Rais, 1996). Co-feeding 
transmission occurs when infected and uninfected ticks feed close to each other in space and 
time. The spirochete will then use the host as a bridge to go from an infected tick to an 
uninfected tick (Randolph et al., 1996; Randolph, 2011; Voordouw, 2015). 
This alternative mode of pathogen transmission was first discovered in tick-borne viruses 
including Thogoto virus (Jones et al., 1987), tick-borne encephalitis virus (TBEV) (Labuda et 
al., 1993), and Bunyavirus (Labuda et al., 1997a). Gern and Rais (1996) were the first to show 
that co-feeding transmission occurs among Borrelia pathogens. Effective co-feeding 
transmission requires a particular set of ecological conditions. One very important condition is 
that nymphal ticks and larval ticks search for hosts at the same time of the year (Randolph et 
al., 1999). In Europe, larval and nymphal host searching behavior is more synchronized 
whereas in North America, the peak questing activity of the two immature tick stages is 
separated by several months (Figure 1) (Kurtenbach et al., 2006). The difference in tick 
phenology between Europe and North America may be why co-feeding transmission is more 
important for European than North American Borrelia genospecies (Voordouw, 2015). 
Theoretical models have shown that co-feeding transmission makes a modest contribution 
to the fitness of Borrelia pathogens (Hartemink et al., 2008; Harrison et al., 2011; Harrison 
and Bennett, 2012). Recent work on B. afzelii has shown that there are differences in the 
efficacy of co-feeding transmission between strains (Tonetti et al., 2015). Some strains of B. 
afzelii are efficiently transmitted by co-feeding and systemic transmission whereas other 
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strains do not have co-feeding transmission (Tonetti et al., 2015). A recent study by Durand et 
al. (2015) found a correlation between the prevalence of B. afzelii in wild ticks and the ability 
of the spirochetes to use the two types of transmission. The strains that were most common in 
wild ticks had the highest levels of co-feeding and systemic transmission in laboratory mice 
(Durand et al., 2015; Tonetti et al., 2015). This result suggests that co-feeding transmission is 
associated with an infection phenotype that has high fitness and reaches high frequency in 
nature. 
 
1.1.7. Cofeeding transmission and acquired immunity: 
Co-feeding transmission could be a strategy for vector-borne pathogens to escape the 
negative effects of the host immune system. Labuda et al. (1997b) showed that antibodies 
developed against TBEV viremia did not prevent co-feeding transmission of this pathogen. 
Previously exposed mice have life-long immunity against TBEV suggesting that co-feeding 
transmission is one method by which tick-borne pathogens avoid the adaptive immune 
response of resistant hosts (Labuda et al., 1997b). Recent work on B. afzelii has found that 
there is substantial variation in the efficacy of co-feeding transmission among strains (strains 
were defined by their genotype at the ospC locus) (Tonetti et al., 2015). Wild rodents are 
often infected with multiple ospC strains indicating that mice are repeatedly exposed to 
infected ticks (Pérez et al., 2011; Andersson et al., 2013). This scenario suggests that ospC 
strains in questing nymphs commonly encounter mice that have developed protective OspC-
specific antibodies because of an earlier exposure to that same strain. Under these 
circumstances (i.e. frequent re-exposure to the same ospC strain), we expect Borrelia 
pathogens to be under strong selection to evade the acquired immune response in the 
vertebrate host. Co-feeding transmission may be a strategy that allows Borrelia pathogens to 
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escape sterilizing antibodies in the vertebrate host. However, whether Borrelia pathogens are 
capable of co-feeding transmission on immunized hosts is currently unknown.  
1.1.8. The role of the OspC protein: 
Pal et al. (2004a) and Fingerle et al. (2007) found that Borrelia mutants lacking the ospC 
gene were unable to migrate from the tick midgut to the tick salivary glands. In contrast, the 
research by the group of Patricia Rosa showed that mutants lacking the ospC gene were able 
to invade the tick salivary glands but were not able to establish infection in the rodent host 
(Tilly et al., 2006; Tilly et al., 2009). There is also controversy regarding the identity of the 
ligand of the OspC protein. The study by Ramamoorthi et al. (2005) suggests that the OspC 
antigen binds the tick salivary gland protein Salp15, which allows the spirochete to evade the 
host immune system. Another study found that the OspC antigen binds the plasminogen 
protein of the vertebrate host, which allows the spirochete to degrade the extracellular matrix 
in the connective tissue and disseminate from the site of the tick bite to the other tissues of the 
vertebrate host (Onder et al., 2012). In summary, there is a controversy about when the OspC 
protein is important (within the tick or within the vertebrate host) and what ligand it binds 
(Radolf and Caimano, 2008; Earnhart et al., 2010). What is certain is that the OspC antigen 
plays a critical role in the tick-to-host transmission of Borrelia spirochetes. 
After establishing a systemic infection in the host, Borrelia pathogens down-regulate 
expression of the ospC gene. The OspC-specific IgG antibody response therefore does not 
allow the mouse to clear the Borrelia infection. In contrast, this mouse is still susceptible to 
being infected by a different ospC strain (Probert et al. 1997). Probert et al. (1997), using a 
rOspC immunization trial and three different strains of B. burgdorferi s. s., were the first to 
show that antibodies developed against a particular ospC strain do not provide cross-
protection against strains carrying a different ospC allele.    
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1.1.9. Multiple strain infections in ticks and hosts: 
An interesting aspect of the biology of B. burgdorferi s. l. is the high diversity of strains 
within each genospecies. Each of the three known Lyme disease pathogens (B. burgdorferi s. 
s., B. afzelii, and B. garinii) consists of multiple strains that are often differentiated by the 
single-copy, highly polymorphic ospC gene (Wilske et al., 1986; Theisen et al., 1993; Wilske 
et al., 1993; Wang et al., 1999a; Qiu et al., 2002; Brisson and Dykhuizen, 2004; Earnhart and 
Marconi, 2007c; Pérez et al., 2011; Andersson et al., 2013; Durand et al., 2015; Strandh and 
Raberg, 2015). OspC induces a strong antibody response in the vertebrate host (Dressler et al., 
1993; Fung et al., 1994; Engstrom et al., 1995).  
Selection by the immune system of the vertebrate host on the OspC protein explains why 
this antigen is so diverse. The spirochete expresses the OspC protein during the tick-to-host 
lifecycle transition. During tick-to-host infection, the vertebrate host is exposed to and 
develops antibodies against the OspC protein. This antibody response takes time to develop 
and does not allow the host to clear the first infection. However, the OspC-specific antibodies 
do protect the host from reinfection with Borrelia strains carrying the same ospC gene 
(Gilmore et al., 1996). In the case where the secondary strain carries a different ospC gene 
from the primary strain, the antibodies are not protective and multiple infection is possible.  
In the wild, multiple infections are common in both rodents and ticks (Wang et al., 1999b; 
Brisson and Dykhuizen, 2004; Swanson and Norris, 2008; Pérez et al., 2011; Andersson et al., 
2013; Durand et al., 2015; Tonetti et al., 2015). The frequency of mixed infections shows the 
importance of carrying a different ospC gene to be able to super-infect hosts already infected 
with another Borrelia strain. 
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1.1.10. Vaccination against Lyme disease: 
Following the commercial failure of the Lymerix vaccine for humans in the United-States 
(Nigrovic and Thompson, 2007), scientists became interested in developing vaccines that 
target the reservoir hosts (Cross et al., 2007). Vaccination of reservoir hosts has been used to 
reduce the incidence of other zoonotic diseases such as rabies (Pastoret and Brochier, 1998). 
In one of the two field vaccination trial conducted to date, Tsao et al. (2004) found that 
immunization of the white-footed mouse (Peromyscus leucopus), one of the most important 
reservoir host of B. burgdorferi sensu stricto in North America (Anderson et al., 1987; 
Bunikis et al., 2004a), produced a modest reduction in the prevalence of infected nymphs and 
thus the human risk of Lyme disease. In Europe, few studies have been done on this subject, 
which is partially due to a higher complexity of the European Lyme disease system 
(Kurtenbach et al., 1994). Both the number of Borrelia species and the strain diversity within 
each species (Derdakova and Lencakova, 2005) are higher in Europe, which makes it more 
complicated to develop effective vaccines.  
The anti-Lyme disease vaccines are based on the outer surface proteins (Osp) of B. 
burgdorferi such as OspC, which was previously described. In fact, there are six different 
Osps in Borrelia labeled OspA to OspF. Each Osp has its own form and function and a 
vaccine targeting OspA will not induce an immune response against, for example, OspC 
(Simon et al., 1999; Wallich et al., 2001). The outer surface proteins are up or down-regulated 
by the bacteria depending on the stage of the spirochete life cycle (i.e. unfed tick, feeding tick, 
rodent, etc.) (Bockenstedt et al., 1997; Wang et al., 1999a; Liang et al., 2004; Battisti et al., 
2008). OspA and OspC have been the most studied outer surface proteins in B. burgdorferi s. 
l. pathogens. The OspA protein in particular, has been the focus of many vaccination studies 
(Fikrig et al., 1990; Fikrig et al., 1992a; De Silva et al., 1996; Tsao et al., 2001; Tsao et al., 
2004). This protein is an interesting candidate for a Lyme disease vaccine because it is highly 
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conserved between Borrelia genospecies and strains (Fikrig et al., 1992b; Probert and 
Lefebvre, 1994; Kurtenbach et al., 1997; Tsao et al., 2001). This protein is expressed inside 
the tick where it functions to anchor the spirochete to the tick midgut (De Silva et al., 1996; 
Schwan and Piesman, 2000; Schwan, 2003; Pal et al., 2004b; Hodzic et al., 2005). There is 
little genetic variation in the ospA gene within each Borrelia genospecies and a given OspA 
vaccine therefore targets all the strains of that species (i.e. the vaccine is said to be multi-
competent) (Probert et al., 1997). Antibodies directed against recombinant OspA proteins 
have been shown to kill the spirochete directly inside the tick. Thus hosts immunized with 
rOspA are never actually exposed to the OspA antigen on the spirochete. Studies on the 
Lymerix vaccine found that humans would have to be vaccinated repeatedly to maintain 
protective antibodies against the Lyme disease pathogen. 
The other vaccine candidate that has been investigated is OspC (Probert and Lefebvre, 
1994; Wallich et al., 2001; Gilmore et al., 2003; Brown et al., 2005; Earnhart and Marconi, 
2007b). The OspC protein is expressed when the spirochete invades the vertebrate host from 
the tick vector (Schwan et al., 1995; Gilmore and Piesman, 2000; Grimm et al., 2004; Pal et 
al., 2004a; Tilly et al., 2006; Fingerle et al., 2007). As previously described, and in contrast to 
ospA, the ospC gene is highly genetically variable and this variability has likely evolved in 
response to the host immune system (Wang et al., 1999b). A vaccine consisting of a specific 
recombinant OspC protein will be protective only against the strain carrying this particular 
ospC allele (Probert et al., 1997; Jacquet et al., 2015). The possibility of using a multivalent 
OspC vaccine has been studied but the number of ospC strains is high, which complicates the 
task (Earnhart et al., 2005; Earnhart and Marconi, 2007b).  
Vaccination with a specific recombinant OspC protein can be a way to target only one 
strain and study the effects of the acquired immune response on the transmission of B. afzelii.  
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1.1.11. Objectives of the PhD project:  
The purpose of the present work was to test whether co-feeding transmission allows 
the B. afzelii pathogen to evade the acquired immune response of the rodent reservoir host. 
We used immunization trials with recombinant OspC proteins against different ospC strains 
of B. afzelii to test hypotheses about the evolutionary ecology of ospC strains in nature in 
addition to providing complementary information on the feasibility of rOspC-based vaccines 
(Earnhart and Marconi, 2007b, c, a). From an evolutionary perspective, we are interested to 
test whether previous immune experience with the OspC antigen is effective at reducing 
systemic transmission and co-feeding transmission of B. afzelii. In addition, we are interested 
in understanding how vaccination of reservoir hosts with rOspC-based vaccines will affect the 
epidemiology and evolution of the targeted Lyme disease pathogens (Tsao, 2009; Balmer and 
Tanner, 2011). 
In this study, we tested whether immunization with recombinant OspC proteins prevented 
co-feeding transmission of that particular ospC strain of B. afzelii. If rOspC immunization of 
reservoir hosts reduces systemic but not co-feeding transmission, a rOspC-based vaccine 
targeting reservoir hosts might favor the evolution of those strains capable of co-feeding 
transmission. This vaccine-induced change in the selective landscape may result in rapid 
fixation of co-feeding ospC strains with potentially unknown outcomes for human Lyme 
disease risk. We also tested the effects of cross-immunity on the spirochete load of infected 
ticks. In addition, we investigated how the age of the B. afzelii infection in the rodent host 
influenced the rate of systemic transmission and the spirochete load in ticks fed on mice. 
Finally, we investigated how aging in the ticks influenced the spirochete persistence and 
spirochete load in B. afzelii-infected nymphs. 
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2. Protocol of the experiment: 
2.1. Principle of the experiment: 
The purpose of this experiment was to test whether adaptive immunity in rodent reservoir 
hosts prevents co-feeding transmission of B. afzelii. Our experiment essentially simulated the 
scenario where a particular B. afzelii ospC strain encounters a host that has been previously 
exposed to the same strain and has developed a strong antibody response to it. To induce 
adaptive immunity without infecting the mice, we immunized the mice with recombinant 
OspC (rOspC). To test whether ospC strains capable of co-feeding transmission have a fitness 
advantage in immune-competent hosts, we compared the transmission success between ospC 
strains that were previously shown to differ in their efficacy of co-feeding transmission on 
laboratory rodents (Tonetti et al., 2015). In addition, we tested whether immunization with 
recombinant OspC provides cross-protection against strains carrying different ospC alleles. 
Importantly, we challenged immunized mice with ticks (i.e. the natural mode) rather than 
needles to determine the efficacy of protection.   
 
2.2. Timeline of the work conducted during the PhD thesis: 
From September to December 2011, we established the goals of this PhD project. 
From January 2012 to May 2013, we developed the recombinant OspC proteins that were 
used for the immunization.  
From 24 April 2012 to 26 July 2012, we created the “challenge” nymphs infected with 
either strain A3 or strain A10. Ten mice were infected via tick bite with one of the two strains. 
The mice were infested with two batches of xenodiagnostic larvae. The blood-engorged larvae 
were collected and allowed to molt into nymphs. These “challenge” nymphs were used to 
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challenge the mice in the immunization trial in 2013. Ticks were checked every month and 
sampled twice to determine their infection status on 9 August 2012 and 7 February 2013.  
For the main immunization experiment, the 42 mice were received on 30 April 2013 and 
were sacrificed on 14 November 2013 (7.5 months). Four immunization treatments, one 
infectious challenge and four xenodiagnoses were conducted on these mice. Ticks collected 
from those xenodiagnoses were allowed to molt and then killed at different period. The last 
tick sampling was done on 24 January 2014. 
ELISA analysis of serum samples and DNA extraction of ticks followed by qPCR were 
done during 2014 and the first 6 months of 2015. The last qPCR was done on 10 June 2015. 
The statistical analysis of the data and the writing of this manuscript were done between 
February 2014 and September 2015. 
During this PhD thesis, I also gave some practical courses to 1
st
 and 3
rd
 year Bachelor 
students in histology (spring semester) and in statistics (autumn semester). We also developed 
a course on molecular biology techniques for the Master students in parasitology (autumn 
2013). 
 
2.3. General methods: 
2.3.1 B. afzelii ospC strains: 
We used B. afzelii isolates E61 and NE4049. These isolates were originally obtained from 
xenodiagnostic ticks that had been sampled from field-captured mice (Pérez et al., 2011; 
Tonetti et al., 2015). Using the nomenclature of Bunikis et al. (2004b), isolates E61 and 
NE4049 carried the major ospC groups A3 (GenBank accession number: L42890) and A10 
(GenBank accession number: JX103488), respectively (Tonetti et al., 2015). Isolates were 
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grown in BSK culture at 32°C and stored at -80°C. 454-sequencing analysis shows that our 
strains were essentially monogenic for the major ospC group allele of interest. The co-feeding 
and systemic transmission success of these two strains was previously described by Tonetti et 
al. (2015). Strain A3 has medium systemic transmission (50% of xenodiagnostic larvae were 
infected) but no co-feeding transmission whereas strain A10 has both high systemic 
transmission (85%) and co-feeding transmission (65%).  
2.3.2 Production of B. afzelii-infected nymphs and B. afzelii antiserum:  
B. afzelii isolates E61 and NE4049 (ospC strains A3 and A10) were inoculated into 
BALB/c mice (Tonetti et al., 2015). Mice were infested with xenodiagnostic larval ticks and 
blood-engorged larvae were allowed to molt into nymphs. These nymphs were used to infect 
five BALB/c mice for each of the two strains. Each mouse was infested with ~100 
xenodiagnostic larval ticks at two and four months after the nymphal challenge and blood-
engorged larvae were allowed to molt into nymphs. When the nymphs were two months old, 
we randomly selected 10 nymphs for each mouse (total of 50 nymphs for each strain) and 
used qPCR to estimate the nymphal infection prevalence. We repeated this assay of the 
nymphal infection prevalence when the nymphs were 8 months old. For strain A3, the 
infection prevalence was 76.7% (23/30) for the 2-month-old nymphs and 80.0% (16/20) for 
the 8-month-old nymphs. For strain A10, the infection prevalence was 90.0% (27/30) for the 
2-month-old nymphs and 70.0% (14/20) for the 8-month-old nymphs. All mice were 
exsanguinated three months after infection. The sera from these mice were used to test 
whether our rOspC proteins contained the same epitopes as native OspC protein in the B. 
afzelii pathogen. The nymphs that remained from the first xenodiagnostic batch were used to 
challenge the immunized mice when the nymphs were 11 months old. 
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2.3.3 Production of the recombinant OspC Proteins:  
We produced recombinant OspC proteins for major ospC groups A3 and A10. The DNA 
for these two ospC strains came from isolates E61 and NE4049. The ospC gene sequences 
were amplified with primers modified from Earnhart et al. (2005), which contained restriction 
sites and a stop codon on the reverse primer: 
OspC forward + 5’ BamHI site (green):   
5’ – GTATAGGATCCAATAATTCAGGGAAAGGTGG – 3’ 
OspC reverse + 5’ HincII site (green) + Stop codon (red):  
5’ – CATGGTCGACTTAAGGTTTTTTTGGGGTTTCTGC – 3’ 
The PCR amplicon of the ospC was inserted into the pGEM-t easy vector (PROMEGA). 
The ospC gene + plasmid complex was digested with BamHI and HincII restriction enzymes 
and the digestion product was ligated into the pQE-30 Xa plasmid (QIAGEN). We sequenced 
the recombinant plasmid to ensure that the ospC gene was in-frame. The pQE-30 Xa plasmid 
carries a 6xHis tag to facilitate protein purification. The ospC-pQE-30 Xa construct was 
transformed into Escherichia coli (strain JM109). Recombinant E. coli cells were grown in 
200 ml of LB media to a density of 10
9
 cells/ml and rOspC-expression was induced by adding 
IPTG (250 µM) for one hour. Proteins were purified using the QIAGEN Ni-NTA protein 
purification kit and was followed by a dialysis in PBS. We also sent the ospC-pQE-30 Xa 
construct to ImmBiomed Company (Germany) who produced and purified the rOspC 
proteins. Purification was done using His-Tag affinity chromatography followed by gel 
filtration. 
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2.3.4 Experimental Design:  
Female BALB/c mice were randomly assigned to one of three immunization treatments: 
(1) control immunization with phosphate-buffered solution (PBS), (2) immunization with 
rOspC-A3, and (3) immunization with rOspC-A10. All mice were subsequently challenged 
via tick bite with either strain A3 or A10. Thus there were a total of 6 combinations of 
immunization treatment and B. afzelii strain as listed below: 
Control A3: Immunized with PBS, challenged with B. afzelii ospC strain A3 
Control A10: Immunized with PBS, challenged with B. afzelii ospC strain A10 
Homologous A3: Immunized with rOspC type A3, challenged with strain A3 
Homologous A10: Immunized with rOspC type A10, challenged with strain A10 
Heterologous A3: Immunized with rOspC type A10, challenged with strain A3 
Heterologous A10: Immunized with rOspC type A3, challenged with strain A10 
The groups control A3 and control A10 each contained 5 mice whereas the other groups 
contained 8 mice for a total of 42 mice in the experiment. Following immunization, each 
mouse was challenged with ten B. afzelii-infected nymphs to test whether immunization with 
rOspC protected mice from infection with B. afzelii. 
 
2.3.5 Immunization of mice with recombinant OspC: 
 Each mouse was immunized subcutaneously once per week for four weeks. A first dose of 
20 µg of rOspC mixed with Freund’s Complete Adjuvant (FCA) was followed by 3 booster 
doses of 10 µg of rOspC mixed with Freund’s Incomplete Adjuvant (FIA). Control mice were 
inoculated with PBS and adjuvant only. Mice were bled two days before the first 
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immunization and 10 days after the fourth immunization to determine seroconversion. The 
mouse sera were used in a subsequent ELISA to test whether the mice had developed OspC-
specific IgG antibodies against the OspC antigen. 
 
2.3.6 Nymphal Challenge: 
Immunized and control mice were challenged with B. afzelii-infected nymphs two weeks 
after the last immunization. Each mouse was infested with 10 nymphs that were infected with 
the appropriate strain of B. afzelii. Nymphs were placed in a plastic capsule (diameter of 1 
cm) that had been attached to the skin of the mouse to protect the ticks from mouse grooming 
behavior during the attachment phase. Infested mice were placed in cages with a metal grill 
floor that facilitated collection of blood-engorged ticks. After dropping off the mice, the 
blood-engorged ticks fell through the grill floor into the collecting trays below. The blood-
engorged nymphs were immediately frozen at -20°C for future analysis. 
 
2.2.6 Xenodiagnosis to measure mouse-to-tick transmission success: 
We infested mice with pathogen-free larval ticks from our laboratory colony of Ixodes 
ricinus to measure co-feeding and systemic transmission of each strain. To measure co-
feeding transmission, mice were infested with larval ticks 48 hours after attachment of 
nymphal ticks. The 50 to 100 larvae were placed in the plastic capsule to ensure that the two 
tick stages fed in close proximity to each other, which enhances the probability of co-feeding 
transmission. To measure systemic transmission of each strain, all mice were infested with 50 
to 100 larval ticks at 34, 66, 94, and 128 days (corresponding to 1, 2, 3, and 4 months) after 
the nymphal challenge. Infested mice were placed in special cages that facilitated the 
collection of blood-engorged larval ticks. Blood-engorged larvae were placed in 1.7 ml tubes 
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with a piece of moist filter paper and allowed to molt into nymphs (~ 30 days). Random 
samples of ticks were frozen at -20°C at 1, 2, 3, or 4 months after molting. 
2.2.7 qPCR to detect Borrelia infection in ticks and mouse tissue: 
We used qPCR to determine B. afzelii infection status of the challenge nymphs and 
xenodiagnostic larvae. The qPCR protocol targets a 132 bp fragment of the highly conserved 
flagellin gene using primers and a probe previously described by Schwaiger et al. (2001). 
 
2.4. Output data: 
The experiment collected the following output data: 
1) ELISA on blood samples three weeks after the last immunization to show that 
immunized mice developed an OspC-specific IgG antibody response against the rOspC 
antigen.  
2) Borrelia-infection status of nymphs used to challenge the mice. For the logic of the 
experiment, it is important to confirm that all mice were challenged with at least one B. 
burgdorferi-infected nymph. If we do not recover any infected nymphs or xenodiagnostic 
larvae (molted into nymphs) for a given mouse, we cannot be sure that this mouse was ever 
challenged with B. burgdorferi. A conservative approach would exclude such individuals 
from the statistical analysis. 
3) Ear biopsy from the mice four weeks after the infectious challenge. The ear biopsy 
allowed us to establish whether the mice were systemically infected with B. afzelii or not. 
4) Borrelia infection status of the xenodiagnostic larvae (molted into nymphs). The 
infection prevalence of the xenodiagnostic ticks allows us to estimate the rates of co-feeding 
transmission and systemic transmission for the two different strains of B. afzelii. The 
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xenodiagnostic ticks from the infestation 1 month after the infectious challenge also allowed 
us to test whether the mice were systemically infected with B. afzelii or not. 
5) Xenodiagnostic larval ticks were fed on mice at 1, 2, 3, and 4 months after the 
infectious challenge. This data allows us to test whether the age of the infection inside the 
mouse influences the systemic transmission rate and the spirochete load of the nymphal ticks. 
6) Xenodiagnostic larval ticks that had molted into nymphs were killed at 1, 2, 3, and 4 
months after the larva-to-nymph molt. This data allows us to test whether the spirochete load 
changes over time as the nymph and the Borrelia infection age together.  
 
2.5. Maintenance of the laboratory colony of Ixodes ricinus ticks: 
The laboratory colony of Ixodes ricinus ticks at the University of Neuchatel was created 
over 30 years ago. No ticks from the wild were added to the colony during this period to avoid 
contaminating the colony with tick-borne pathogens. Below, I give a brief description of how 
the laboratory colony of I. ricinus ticks is maintained. 
Larval ticks are fed on mice. These mice are anesthetized using a mix of ketamine, 
xylazine and PBS (ratio 1:2:9, 1µl/g of animal). The larval ticks are deposited on the head of 
the mice allowing them to attach for the duration of the anesthetic (30 to 45 minutes). Larvae-
infested, anesthetized mice are placed in type 2 cages. Each type 2 cage is placed inside a type 
3 cage containing a thin layer of water (2 cm). When ticks drop off the mice at the end of the 
blood meal, they are looking for a moist place to molt. The blood-engorged larval ticks climb 
up the walls of the type 2 cage and fall into the type 3 cage containing the water. The floating 
ticks are easily collected. Using entomological forceps, ticks are dried on filter paper and then 
placed in glass tubes in order to molt. The tube is closed with a perforated cap that allows the 
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air to circulate. The glass tubes are placed in a plastic box with a small container of water that 
maintains a high relative humidity to facilitate efficient molting of the ticks. 
Nymphs and adult ticks are fed on rabbits. Tick-infested rabbits are placed in a 
containment box adapted to this purpose. Sock-like covers are placed over the ears of the 
rabbit to prevent the ticks from escaping during the blood meal. A neck brace is used to 
prevent the rabbit from removing the socks. After the first 3 days, the socks are checked twice 
per day to collect ticks that would have died or dropped off. After collecting all the blood-
engorged ticks (7 or 8 days), the rabbit is returned to the communal rabbit pen. Engorged 
nymph and adult ticks are kept the same way as the larvae. Male and female adult ticks are 
put together in the socks on the rabbit ears allowing them to mate. Blood-engorged females 
are placed in individual glass tubes (sometime with the mating male) to lay eggs. Once the 
larvae hatch the cycle starts again. 
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Pathogen transmissioncross-reactive antibodies can reduce pathogen transmission at the vector-to-host and the host-to-vector lifecycle
transition. The highly polymorphic, immunodominant, outer surface protein C (OspC) of the tick-borne spiro-
chete bacterium Borrelia afzelii induces a strong antibody response in the vertebrate host. To test how cross-
immunity in the vertebrate host inﬂuences tick-to-host and host-to-tick transmission, mice were immunized
with one of two strain-speciﬁc recombinant OspC proteins (A3, A10), challenged via tick bite with one of the
two B. afzelii ospC strains (A3, A10), and infestedwith xenodiagnostic ticks. Immunizationwith a given rOspC an-
tigen protectedmice against homologous strains carrying the samemajor ospC group allele but provided little or
no cross-protection against heterologous strains carrying a different major ospC group allele. There were cross-
immunity effects on the tick spirochete load but not on the probability of host-to-tick transmission. The spiro-
chete load in ticks that had fed onmicewith cross-immune experience was reduced by a factor of two compared
to ticks that had fed on naive control mice. In addition, strain-speciﬁc differences inmouse spirochete load, host-
to-tick transmission, tick spirochete load, and the OspC-speciﬁc IgG response revealed the mechanisms that de-
termine variation in transmission success between strains of B. afzelii. This study shows that cross-immunity in
infected vertebrate hosts can reduce pathogen load in the arthropod vector with potential consequences for
vector-to-host pathogen transmission.
© 2015 Elsevier B.V. All rights reserved.Borrelia burgdorferi sensu lato (s. l.) is a genospecies complex of tick-1. Introduction
borne spirochete bacteria that includes the causative agents of Lyme dis-Cross-reactive acquired immunity occurs when the antibodies de-
veloped against one pathogen strain interfere with the fate of another
pathogen strain. Antibodies developed against an earlier, primary infec-
tion may prevent the establishment of a later, secondary infection or
reduce the density of the secondary strain in the host tissues. Cross-
reactive acquired immunity (or cross-immunity) induces indirect com-
petition between strains and is critical for structuring the ecology of
mixed infections (Frank, 2002; Read and Taylor, 2001). In vector-
borne infections, acquired immunity can reduce pathogen transmission
success at two critical steps in the pathogen life cycle: vector-to-host
transmission and host-to-vector transmission. Previous work has
shown that host-to-vector transmission success often depends on the
density of the pathogen in the host tissues at the time of vector attach-
ment (de Roode et al., 2005; Mackinnon et al., 2008; Raberg, 2012).
Thus cross-immunity, by reducing the density of competing pathogen
strains inside the host, might have important consequences for host-
to-vector transmission success.
⁎ Corresponding author.
t).ease in Europe andNorthAmerica (Kurtenbach et al., 2006). This zoonotic
pathogen ismaintained in nature by cycles involving Ixodes ticks and ver-
tebrate reservoir hosts such as birds and small mammals. Each Borrelia
genospecies, in turn, consists of multiple strains that are often differenti-
ated by the single copy, highly polymorphic ospC gene (Andersson et al.,
2013b; Brisson and Dykhuizen, 2004; Durand et al., 2015; Earnhart and
Marconi, 2007c; Perez et al., 2011; Qiu et al., 2002; Strandh and Raberg,
2015; Theisen et al., 1993; G. Wang et al., 1999; Wilske et al., 1986,
1993). The ospC gene codes for the immunodominant outer surface pro-
tein C (OspC), which induces a strong antibody response in the vertebrate
host (Dressler et al., 1993; Engstrom et al., 1995; Fung et al., 1994). The
anti-OspC IgG response provides protection against secondary infection
(Gilmore et al., 1996; Preac-Mursic et al., 1992; Probert and Lefebvre,
1994). A study on the North American genospecies of B. burgdorferi
sensu stricto (s. s.) showed that immunization with OspC provides pro-
tection only against strains carrying that particular ospC allele suggesting
that there is no cross-protective immunity (Probert et al., 1997). Similarly,
a sequential infection experiment with two strains of B. burgdorferi s. s.
carrying different ospC alleles found no evidence for cross-protective im-
munity (Derdakova et al., 2004). In contrast, a recent study on the
European genospecies of Borrelia afzelii in wild rodents found a pattern of
co-occurrence between ospC strains suggesting that cross-immunity was
is that the laboratory ticks have a reduced microbial symbiont commu-
nity compared to wild I. ricinus ticks (Lo et al., 2006). Ixodes ticks with
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(Andersson et al., 2013b). Thus despite the fact that the OspC antigen has
received extensive study, the pattern of protective cross-immunity be-
tween the different ospC strains is notwell understood formostmembers
of the B. burgdorferi s. l. genospecies complex.
Acquired immunity against Borrelia pathogens can reduce the efﬁcacy
of host-to-tick transmission. Immunization of infected mice with outer
surface protein A (OspA) reduced the transmission rate of B. burgdorferi
s. s. (Bhattacharya et al., 2011; Gomes-Solecki et al., 2006; Richer et al.,
2014; Tsao et al., 2001; Voordouw et al., 2013). However, this
transmission-blocking acquired immunity does not occur under natural
conditions because the spirochetes rarely express the OspA antigen inside
the vertebrate host (De Silva and Fikrig, 1997; De Silva et al., 1996). In
contrast, the OspC antigen is expressed inside the vertebrate host
(Crother et al., 2004; Liang et al., 2004; Zhong et al., 1997) and so OspC-
speciﬁc antibodies could potentially reduce host-to-tick transmission. In
particular, hostswith previous immune experiencewith theOspC antigen
may develop a faster and more effective anti-OspC IgG response against
secondary infections carrying a different ospC allele. In B. burgdorferi s. s.,
shared epitopes between different OspC antigens can create cross-
reactive antibodies (Ivanova et al., 2009). Thus the purpose of the present
studywas to test whether antibodies against a givenOspC antigen can in-
ﬂuence the host-to-tick transmission success and tick pathogen load of a
strain carrying a different ospC allele. To isolate the effect of cross-
immunity and avoid direct competition between strains, we used recom-
binant OspC (rOspC) proteins to induce an OspC-speciﬁc antibody re-
sponse, thereby removing the confounding effect of a resident primary
infection. We predicted that immunization with the rOspC antigen
would protectmice against infectious challenge (via tick bite)with strains
carrying the same ospC allele (homologous strain) but not against strains
carrying a different ospC allele (heterologous strain). We also predicted
that cross-immunity would reduce the host-to-tick transmission rate
and the tick spirochete load. Speciﬁcally, we predicted that these two spi-
rochete phenotypes would be lower in infected mice that had immune
experience with the heterologous rOspC antigen compared to infected
mice that had no immune experience with the rOspC antigen.
2. Materials and methods
2.1. Mice and ticks
Four-week-old, pathogen-free, femaleMus musculus BALB/cByJ mice
(Charles River, l'Arbresle, France) were housed in groups of four or ﬁve
with ad libitumaccess to food andwater (Protector, Switzerland). The an-
imalswere allowed to adjust to their newsurroundings for sevendays be-
fore the start of the experiment. Mice were housed individually following
infectious challenge with B. afzelii to avoid any direct transmission be-
tween animals. The mice were euthanized 28 weeks after entering our
animal care facility. The commission that is part of the ‘Service de la
Consommation et des Affaires Vétérinaires (SCAV)’ of Canton Vaud,
Switzerland evaluated and approved the ethics of this study. The Veteri-
nary Service of the Canton of Neuchâtel, Switzerland issued the animal
experimentation permit used in this study (NE2/2012). Ixodes ricinus
ticks came fromour pathogen-free, laboratory colony that has beenmain-
tained for over 33 years at the Institute of Biology,University ofNeuchâtel.
To ensure that this I. ricinus colony remains pathogen-free, no wild-
caught ticks have been introduced into the colony since its establishment.
Host-to-tick transmissionwas recently compared between laborato-
ry andwild I. ricinus ticks infectedwith one of the two strains of B. afzelii
used in this study (A10) and BALB/c mice. Host-to-tick transmission of
strain A10 was 85.5% for the laboratory ticks (Tonetti et al., 2015) and
64.0% (64 infected/100 total) for the wild ticks (unpublished data).
This comparison suggests that laboratory ticks are more competent at
acquiring B. afzelii than wild ticks. One explanation for this differenceexperimentally reducedmicrobial symbiont communities aremore sus-
ceptible to infection with B. burgdorferi s. l. pathogens (Narasimhan
et al., 2014).
2.2. B. afzelii isolates and the major ospC group allele
B. afzelii isolates E61 andNE4049were chosen for this study because
both isolates are highly infectious to laboratory mice via tick bite
(Tonetti et al., 2015). The origins of these isolates and their capacity
for tick-to-host transmission and systemic (host-to-tick) transmission
were described in a previous study (Tonetti et al., 2015). Both isolates
had been passaged fewer than ﬁve times to avoid the loss of the viru-
lence genes that are critical for infection (Tonetti et al., 2015). The
ospC alleles of a given Borrelia species are often clustered into what
are called major ospC groups that are deﬁned as beingmore than 8% di-
vergent at theDNA sequence level fromall other such groups (I.N.Wang
et al., 1999). B. afzelii contains at least 19 different major ospC groups
(Strandh and Raberg, 2015). There are currently two different systems
of nomenclature for the major ospC groups of B. afzelii: one developed
by Lagal et al. (2003) and the other developed by Bunikis et al. (2004).
Using the nomenclature of Bunikis et al. (2004), isolates E61 and
NE4049 carried the major ospC groups A3 (GenBank accession number:
L42890) and A10 (GenBank accession number: JX103488), respectively
(Durand et al., 2015; Tonetti et al., 2015). The genetic distance between
major ospC groups A3 and A10 is intermediate (20.7%) compared to
other such pairs (8.9–26.4%; Durand et al., 2015). Thus if cross-
immunity effects occur for this intermediately divergent pair of major
ospC groups, it is likely to exist for pairs that are genetically more similar.
Hereafter, we refer to isolates E61 andNE4049 as B. afzelii ospC strains A3
and A10, respectively.
Isolates of B. burgdorferi s. l. often contain multiple ospC strains
(Durand et al. 2015; Perez et al., 2011; Qiu et al., 2002). We recently
used deep sequencing to conﬁrm that isolates E61 and NE4049 were
100.0% pure for major ospC groups A3 and A10, respectively (Tonetti
et al., 2015). In the present study, we also used the ospC gene as a
strain-speciﬁc marker to differentiate between strains as numerous
other studies have done (Durand et al., 2015; Andersson et al., 2013b;
Baum et al., 2012; Brisson and Dykhuizen, 2004; Perez et al., 2011;
Tonetti et al., 2015; I.N. Wang et al., 1999). Previous genetic work has
shown that the ospC locus is in linkage disequilibrium with many
other loci in the Borrelia genome (Brisson et al., 2012; Bunikis et al.,
2004; Hellgren et al., 2011; Qiu et al., 2004). We therefore emphasize
that any phenotypic differences between strains A3 and A10 may be
due to genetic variation at these other loci.
2.3. Creation of nymphs infected with B. afzelii ospC strains A3 and A10
Five mice were infected via nymphal tick bite for each of the
two strains of B. afzelii (total of 10 mice). The nymphal ticks used to in-
fect the mice were obtained from a previous experiment (Tonetti et al.,
2015). Four weeks after infection, each mouse was infested with ~100
larval ticks. Blood-engorged larvae were placed in individual tubes
(1.7 ml Eppendorf tubes containing a moistened piece of paper towel)
and were allowed to molt into nymphs. These ﬂat pre-challenge
nymphswere tested for B. afzelii infection using a quantitative polymer-
ase chain reaction (qPCR) at 1 month and 7 months post-molt. The
infection prevalence of the 7-month-old nymphs was 80.0% (16 infect-
ed/20 total) and 70.0% (14 infected/20 total) for strains A3 and A10, re-
spectively (Table 1).
2.4. Production of recombinant OspC proteins
DNAwas isolated from ticks infectedwith B. afzelii ospC strains A3 or
A10 using the QIAGEN DNeasy® Blood & Tissue kit according to the
manufacturer's instructions. The ospC gene, corresponding to the full A3 (n=5) or strain A10 (n=5). One of themice belonging to the rOspC
2.6. Infectious challenge with B. afzelii-infected ticks
2.7. Mouse ear skin biopsies
Table 1
The geometric mean spirochete loads are shown for the subset of Borrelia afzelii-infected Ixodes ricinus nymphs that were used to challenge the immunized mice.
Nymphal statea Nymphal age (months)b B. afzelii strain rOspC immunogen Immunization treatment Infected nymphs/total nymphs Spirochete loadc
Geometric mean (95% C. L.)d
Flat 1 A3 N. A.e N. A. 23/30 1406 (584–3382)
Flat 1 A10 N. A. N. A. 27/30 11,344 (6912–18,619)
Flat 7 A3 N. A. N. A. 16/20 743 (375–1472)
Flat 7 A10 N. A. N. A. 14/20 1537 (471–5014)
Engorged 11 A3 PBS Control 20/34 3530 (1437–8667)
Engorged 11 A3 rOspC A10 Hetero 18/29 1521 (769–3007)
Engorged 11 A3 rOspC A3 Homo 31/58 3159 (1799–5546)
Engorged 11 A10 PBS Control 21/38 2896 (1478–5675)
Engorged 11 A10 rOspC A3 Hetero 31/57 2723 (1468–5050)
Engorged 11 A10 rOspC A10 Homo 37/51 2907 (1750–4861)
a The nymphal state refers to whether the nymphs were ﬂat (pre-challenge) or blood-engorged (post-challenge).
b The nymphal age is the number of months after the larva-to-nymph molt that the nymphs were killed to check their infection status for B. afzelii.
c The spirochete load is the number of spirochetes per nymph.
d 95% conﬁdence limits of the geometric mean.
e N. A. = not applicable.
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modiﬁed from Earnhart et al. (2005). The forward primer contained a
BamH1 restriction site (underlined) in the 5′ end (5′-GT ATA GGA TCC
AAT AAT TCA GGG AAA GGT GG-3′) and the reverse primer contained
a HincII restriction site (underlined) in the 5′ end (5′-C ATG GTC GAC
TTA AGG TTT TTT TGG ACT TTC TGC-3′). DNAwas ligated by T/A cloning
to a pGEM-T plasmid (PROMEGA) and then digested with BamH1 and
HincII restriction enzymes. Digested blunt-ended DNA was ligated to
the BamH1 and HincII sites of the bacterial expression vector
pQE30Xa. ImmBiomed GmbH (Pfungstadt, Germany) performed the
expression and puriﬁcation of the rOspC proteins using His-Tag chro-
matography and gel ﬁltration. The rOspC proteins were dissolved in
PBS (pH 7.0) and their concentrations were determined using a Brad-
ford assay.
2.5. Immunization treatments and infectious challenge
Forty-two mice were randomly assigned to one of three immuniza-
tion treatments: rOspC A3 (n = 16), rOspC A10 (n = 16), or PBS
(n = 10). Each mouse was immunized subcutaneously four times at
weekly intervals (days 1, 8, 15, and 22). The ﬁrst immunization
contained 20 μg of rOspC mixed with Freund's complete adjuvant
(total volume = 100 μl). The second, third and fourth immunizations
contained 10 μg of rOspC mixed with Freund's incomplete adjuvant
(total volume= 100 μl per immunization). Control mice were inoculat-
ed with 100 μl of PBS and adjuvant. Immunized mice were randomly
assigned to infectious challenge via tick bite with one of two B. afzelii
ospC strains: A3 or A10. Thusmice immunizedwith rOspC A3were chal-
lenged with the homologous A3 strain (n = 8 mice) and the heterolo-
gous A10 strain (n = 8 mice) and vice versa for the mice immunized
with rOspC A10 (Table 2). The control mice were challenged with strain
Table 2
The status of B. afzelii infection is shown for the six combinations of the rOspC immunogen and
rOspC immunogen B. afzelii Strain Immunization treatment Ear tissue sample
PBS A3 Control 5/5 (100.0%)
rOspC A10 A3 Heterologous 5/7 (71.4%)
rOspC A3 A3 Homologous 0/8 (0.0%)
PBS A10 Control 5/5 (100.0%)
rOspC A3 A10 Heterologous 8/8 (100.0%)
rOspC A10 A10 Homologous 0/8 (0.0%)
a Proportion of mice that tested positive for B. afzelii infection according to the qPCR of the e
b Proportion of mice that tested positive for B. afzelii infection according to the ELISA using t
c Proportion of mice that produced at least one B. afzelii-infected tick via systemic transmiss
d Systemic transmission rate for all mice (n = 41). Number of infected ticks/total number o
e Systemic transmission rate for the subset of infected mice (n = 23). Number of infected tiA10/strain A3 group died during the experiment so that the ﬁnal sample
size was 41 mice.To test whether immunization was protective, we challenged the
mice with B. afzelii via tick bite two weeks after the last immunization
(day 34). To ensure infectious challenge, each mouse was infested
with ten randomly selected, putatively infected nymphs. To prevent
the challenge nymphs from escaping, they were placed in a plastic cap
(15 mm diameter) that was glued to the shaved backs of the mice
using a mix of resin and honey wax (4:1). Mice were anesthetized
with a mix of xylazine, ketamine and PBS (1:2:9; 5 μl per gram of
mouse) during this procedure. Themicewere checked daily and anyde-
tached, blood-engorged nymphal ticks were removed from the cap and
frozen at−20 °C for further analysis.Ear skin biopsies were taken to test whether the immunization
treatments had protected the mice from infectious challenge. Ear
tissue samples were taken from each mouse four weeks after the
nymphal challenge (day 68) and again seven days later (day 75) using
a forceps type punch (2 mm in diameter). With respect to another
important event in the pathogen life cycle, the two tissue samples
were taken on the day of and oneweek after the infestationwith the xe-
nodiagnostic larvae. For simplicity, these two biopsies will be referred
to as the pre-xenodiagnosis and the post-xenodiagnosis ear tissue
samples.B. afzelii strain.
a VlsE ELISAb Systemic transmissionc Infected ticks
All miced
Infected ticks
Infected micee
5/5 (100.0%) 5/5 (100.0%) 39/50 (78.0%) 39/50 (78.0%)
5/7 (71.4%) 5/7 (71.4%) 36/70 (51.4%) 36/50 (72.0%)
0/8 (0.0%) 0/8 (0.0%) 0/79 (0.0%) NA
5/5 (100.0%) 5/5 (100.0%) 45/50 (90.0%) 45/50 (90.0%)
8/8 (100.0%) 8/8 (100.0%) 73/80 (91.3%) 73/80 (91.3%)
0/8 (0.0%) 0/8 (0.0%) 0/80 (0.0%) NA
ar tissue sample at four weeks post-infection.
he VlsE protein at seven weeks post-infection.
ion at four weeks post-infection.
f ticks (% of infected ticks).
cks/total number of ticks (% of infected ticks).
2.8. Systemic transmission assay reactions. The three standards contained 27,780, 2778 and 278 copies
of the ﬂagellin gene in 5 μl, respectively (see supplementary material
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nostic larval ticks that acquire the spirochete froman infectedmouse. To
measure systemic transmission, each mouse was infested with 50 to
100 xenodiagnostic larvae four weeks after the nymphal challenge
(day 68). The mice were anesthetized during this procedure as de-
scribed above. Infested mice were placed in individual cages that facili-
tated the collection of blood-engorged larvae. Blood-engorged larval
ticks were placed in individual tubes and were allowed to molt into
nymphs. These tubes were stored in plastic cryoboxes at room temper-
ature and high humidity. Four weeks after molting, ten nymphs were
randomly selected for each mouse and frozen at −20 °C for further
analysis (total of 410 nymphs).
2.9. Serum sampling
Oneweek before (day 28) and sevenweeks after (day 83) the infec-
tious challengewith B. afzelii, blood sampleswere collected from the tail
vein of each mouse. Blood samples were spun at 1500 G for 10 min and
the serum was transferred to a new tube.
2.10. Enzyme-linked immunosorbent assay (ELISA)
To determine the speciﬁcity of the anti-OspC IgG response, the mice
serum samples were tested for their ability to bind both the homolo-
gous and the heterologous rOspC antigen. The details for the ELISA pro-
tocol are given in the supplementary material. To test whether themice
were systemically infected with B. afzelii, an ELISA targeting the VlsE
protein was performed on the serum samples taken seven weeks after
the infectious challenge (day 83). The VlsE protein is expressed by
B. burgdorferi s. l. pathogens during systemic infection and is one of
the classical antigens used to determine the infection status of a verte-
brate host. The full-length VlsE antigen used in this study was a gift
from Reinhard Wallich and had been derived from B. burgdorferi s. s.
strain B31-5A3 (Lawrenz et al., 1999). The ELISA protocol for the VlsE
antigen was the same as the one for the OspC antigen.
2.11. DNA extraction of nymphs and mouse ear tissue biopsies
All xenodiagnostic ticks analyzed in this study were killed four
weeks after molting into the nymphal stage. Ticks were crushed using
the TissueLyser II by shaking them with a stainless steel bead (1.4 mm
in diameter) at a frequency of 30 Hz for 1 min. Total DNAwas extracted
for each tick using the DNeasy 96 Blood & Tissue kit well plates
(QIAGEN) and following the manufacturer's instructions. Each DNA
extraction plate contained 94 ticks and two negative DNA extraction
controls (Anopheles gambiaemosquitoes). DNA from the mouse ear tis-
sue samples was extracted using the DNeasy Blood & Tissue kit mini
spin column according to the manufacturer's instructions. We mea-
sured the DNA concentration of all mouse ear tissue samples using a
Nanodrop.
2.12. qPCR to determine spirochete infection
A qPCR amplifying a 132 base pair fragment of the ﬂagellin gene
(Schwaiger et al., 2001) was used to detect and quantify Borrelia DNA.
The 20 μl qPCR mixture consisted of 10 μl of 2× Master Mix (FastStart
Essential DNA Probes Master, Roche Applied Science), 3 μl of water,
0.4 μl of 20 μM primer FlaF1A, 0.4 μl of 20 μM primer FlaR1, 0.2 μl of
10 μM Flaprobe1, and 5 μl of DNA template. The thermocycling condi-
tions included a denaturation step at 95 °C for 10min followedby 55 cy-
cles of 60 °C for 30 s and 95 °C for 10 s using a LightCycler® 96 (Roche
Applied Science, Switzerland). Each sample (tick or mouse ear biopsy)
was run in triplicate. Each qPCR plate contained 28 samples, 3 stan-
dards, and one negative control (all in triplicate) for a total of 96 qPCRfor details). The LightCycler® 96 software (Roche Applied Science,
Switzerland) calculated the standard curves and the absolute number
of spirochetes present in each positive sample. The total spirochete
load for each tick was calculated by multiplying the spirochete load in
5 μl of tick DNA template by the appropriate correction factor.
2.13. Statistical methods
All statistical analyses were done in R version 3.1.0. (R Development
Core Team, 2013).
2.13.1. Quantiﬁcation of the OspC-speciﬁc IgG antibody response
To obtain a reliable measure of OspC-speciﬁc or VlsE-speciﬁc anti-
body activity, the area under the curve of absorbance versus time was
integrated over the ﬁrst 28 min of measurement (hereafter referred to
as the Absorb28 value). The speciﬁcity of the anti-OspC IgG antibody re-
sponse to immunization with one of the two rOspC antigens and to in-
fection with one of the two B. afzelii ospC strains is presented in the
supplementary material.
2.13.2. Deﬁnition of B. afzelii infection status for mice and ticks
Mice or ticks were considered infected if at least two of the three
qPCR runs tested positive for B. afzelii. All mice and the vast majority of
ticks were either deﬁnitively positive (all three runs tested positive) or
deﬁnitively negative (all three runs tested negative). Ticks with ambigu-
ous qPCR results (one or two positive runs) were rare (5.3%= 90/1697)
and the classiﬁcation of their infection status did not inﬂuence the
results.
2.13.3. Effect of rOspC immunization on the mouse-speciﬁc systemic trans-
mission rate
The systemic transmission rate was calculated for each infected
mouse (n = 23 infected mice). The homologous mice were excluded
from this analysis because theywere not infected. A GLMwith binomial
errors was used to test whether the immunization treatment (control,
heterologous), B. afzelii ospC strain (A3, A10), and their interaction had
an effect on the mouse-speciﬁc systemic transmission rate. As the
rodent spirochete load can inﬂuence the probability of host-to-tick
transmission (Raberg, 2012), the above analysis was repeated using
the spirochete load of the pre-xenodiagnosis ear tissue samples as a co-
variate. Mouse ear spirochete load was divided by the DNA concentra-
tion of the ear tissue sample and this ratio was subsequently log-
transformed (see supplementary material for more details). This vari-
able is hereafter referred to as the mouse ear spirochete load.
2.13.4. Effect of cross-immunity on spirochete load inside xenodiagnostic
ticks infected via systemic transmission
The spirochete load of each xenodiagnostic tickwas calculated as the
geometric mean of the three replicate runs (negative runs were exclud-
ed). Similarly, the average xenodiagnostic tick spirochete load for each
infected mouse (n = 23) was calculated as the geometric mean of the
infected ticks (negative ticks were excluded). This variable was log-
transformed to improve normality and then modeled as a linear func-
tion of immunization treatment (control, heterologous), B. afzelii ospC
strain (A3, A10), and their interaction. The homologous mice were ex-
cluded from this analysis because they were not infected. The above
analysis was repeated using the mouse ear spirochete load as a
covariate.
3. Results
In what follows below, the tick spirochete load refers to the total
number of B. afzelii spirochetes inside a tick. The mouse spirochete
load refers to the number of spirochetes inside the ear tissue biopsy.
All means are reported with their standard errors unless otherwise
indicated.
(28.6%= 2/7) was therefore broader than that of the rOspC A3 antigen
against strain A10 (0.0% = 0/8) but the difference was not signiﬁcant.
Fig. 1. Cross-reactive acquired immunity in the mouse had no effect on the systemic
transmission rate of B. afzelii. Strain A10 had signiﬁcantly higher systemic transmission
than strain A3. The sample size was the subset of infected mice (n = 10 control and 13
heterologous). Shown are the means and the standard errors.
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rOspC antigen
Immunizationwith the rOspC antigen induced a strong IgG response
in the mice one week after the last immunization (Fig. S1; Supplemen-
tary material). For the pre-infection serum samples, the mean Absorb28
value of the mice immunized with rOspC A3 (2105 ± 119.3 units) was
26 times higher than that of the control mice (81± 2.8 units). Similarly,
the mean Absorb28 value of the mice immunized with rOspC A10
(2942 ± 99.9 units) was 33 times higher than that of the control mice
(89 ± 2.4 units).
3.2. Infection status of the challenge nymphs
An average of 6.5 blood-engorged nymphs were recovered per
mouse (range = 1–10). For strains A3 and A10, each mouse was chal-
lenged with an average of 3.5 infected ticks (range = 2–10) and 4.2 in-
fected ticks (range = 1 to 9), respectively. Analysis of the blood-
engorged nymphs conﬁrmed that all the mice in the study had been
challenged with at least one B. afzelii-infected nymph. The mean spiro-
chete load inside the pre-challenge ﬂat nymphs decreased over time
(compare month 1 versus month 7 in Table 1). For strains A3 and A10,
the mean spirochete load decreased by 47.2% (p = 0.283) and 86.5%
(p b 0.001), respectively. The spirochete load inside the challenge
nymphs increased over the blood meal (compare pre-challenge ﬂat
nymphs at 7 months versus post-challenge engorged nymphs fed on
the control mice at 11 months in Table 1). Blood feeding increased the
spirochete load of the challenge nymphs for strains A3 and A10 by
375.1% (p = 0.444) and 88.4% (p = 0.067), respectively. We note
here that a previous study on B. burgdorferi s. s. in I. scapularis found
that the nymphal spirochete load increased six-fold over the blood
meal (Piesman et al., 2001). There was no effect of immunization treat-
ment (p= 0.681), strain (p= 0.399), and their interaction (p= 0.342)
on the mean spirochete load inside the post-challenge engorged
nymphs (Table 1).
3.3. Infection status of mice following the infectious challenge
Of the 41 mice, 18 individuals (16 homologous, 2 heterologous)
were protected from the infectious challenge with B. afzelii (Table 2).
The remaining 23 individuals (10 controls, 13 heterologous) became in-
fectedwith one of the two strains of B. afzelii (Table 2). The infection sta-
tus of the mice was determined using three independent tests: (1) the
ear tissue biopsies one month after infectious challenge, (2) the VlsE
ELISA seven weeks after infectious challenge (Fig. S3; supplementary
material), and (3) the xenodiagnostic assay one month after infectious
challenge (Table 2). Importantly, there was 100% agreement between
these three independent lines of evidence (Table 2).
3.4. Antibodies against rOspC provides speciﬁc protection against B. afzelii
All of the ten control mice immunized with PBS became infected
with either strain A3 or strain A10 following the infectious challenge
(Table 2). This result shows that the challenge nymphs were infectious
to immunologically naive mice. The effect of the immunization treat-
ment was highly signiﬁcant (GLMwith binomial errors, p b 0.001). Im-
munization with rOspC induced strong protection against infectious
challenge with the homologous strain but not the heterologous strain.
All of the 16 homologousmicewere protected from infectious challenge
(Table 2) whereas only 2 of the 15 heterologous mice were protected
from infectious challenge (Table 2). These two mice had been immu-
nized with rOspC A10 and challenged with strain A3. The cross-
protective immunity of the rOspC A10 antigen against strain A33.5. Antibodies against rOspC had no effect on the mouse-speciﬁc systemic
transmission rate
For the subset of infected mice (n = 23), the GLM analysis of
the mouse-speciﬁc systemic transmission rate found a signiﬁcant effect
of strain (p = 0.001; Fig. 1) but not of the immunization treatment
(control versus heterologous, p = 0.678; Fig. 1) or the interaction
(p = 0.545). The systemic transmission rate of strain A10 (90.7% =
118/130 ticks; n = 13 mice) was 1.2 times higher than strain A3
(75.0% = 75/100 ticks; n = 10 mice).
The previous analysis was repeated usingmouse ear spirochete load
as a covariate. Themain effect of strain remained statistically signiﬁcant
(p= 0.019). There was a signiﬁcant interaction between immunization
treatment and mouse ear spirochete load (p= 0.033). The relationship
between mouse ear spirochete load and systemic transmission was
therefore examined separately for the control and heterologous mice
(Fig. 2). There was a signiﬁcant positive relationship between mouse
ear spirochete load and systemic transmission in the heterologous
mice (p = 0.035) but not in the control mice (p = 0.667; Fig. 2).
3.6. Effect of immunization treatment and B. afzelii ospC strain on the
mouse ear spirochete load
The repeatability of the mouse ear spirochete load was 0.513
(see supplementary material for details). For the subset of infected
mice (n= 23mice), a two-way ANOVA found no signiﬁcant interaction
between immunization treatment and strain on the mouse ear
spirochete load (p = 0.065). The immunization treatment was not sta-
tistically signiﬁcant (p = 0.918) but there was a signiﬁcant effect of
strain (p = 0.004). The mean mouse ear spirochete load (in a 2 mm
diameter biopsy) for strain A10 (34,716 ± 4732 spirochetes) was 1.9
times higher than strain A3 (18,172 ± 3300 spirochetes).
3.7. Effect of cross-immunity on spirochete load of xenodiagnostic ticks in-
fected via systemic transmission
The repeatability of the log-transformed spirochete load inside the
xenodiagnostic ticks was 0.972 (see supplementary material for de-
tails). The linear model of the log-transformed spirochete load of
the xenodiagnostic ticks found a signiﬁcant effect of immunization
treatment (p = 0.009) and of strain (p = 0.040) but not for the inter-
action (p = 0.535). For strain A3, the mean spirochete load of the
xenodiagnostic ticks infected by the control mice (24,284± 7384 spiro-
chetes/nymph) was 2.3 times higher than the heterologous mice
with previous studies on B. afzelii and B. burgdorferi s. s., which showed
that immunization with rOspC protects mice from infection (Gilmore
Fig. 2. The systemic transmission rate of Borrelia afzelii increases with the spirochete load in the mouse ear tissues. The sample size was the subset of infected mice (n = 10 control and
13 heterologous) and each data point represents a single mouse.
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chete load of the xenodiagnostic ticks infected by the control mice
(32,552± 4589 spirochetes/nymph)was 1.9 times higher than the het-
erologous mice (16,809 ± 3133 spirochetes/nymph). Thus acquired
cross-immunity (in the heterologous mice) reduced by half the spiro-
chete load inside the xenodiagnostic ticks for both strains of B. afzelii
(Fig. 3). Strain A10 established a mean spirochete load in the xenodiag-
nostic ticks that was 1.34 times higher than strain A3 (for the control
mice in Fig. 3).
Including mouse ear spirochete load as a covariate did not change
the conclusions of the previous analysis. None of the 3- or 2-way
interactions between immunization treatment, strain, and mouse ear
spirochete load had a signiﬁcant effect on the xenodiagnostic tick spiro-
chete load. Themouse ear spirochete load itself had no signiﬁcant effect
on the xenodiagnostic tick spirochete load (p = 0.953).4. Discussion4.1. Antibodies against rOspC provides speciﬁc protection against B. afzelii
Immunization with rOspC antigen protected mice from infection
with the matching homologous ospC strain. Our results are consistentFig. 3. Cross-reactive acquired immunity reduced the mean spirochete load of Borrelia
afzelii inside the xenodiagnostic ticks. Strain A10 had a signiﬁcantly higher mean tick spi-
rochete load than strain A3. The sample size was the subset of infectedmice (n= 10 con-
trol and 13 heterologous). Shown are the means and the standard errors.et al., 1996; Preac-Mursic et al., 1992; Probert and Lefebvre, 1994).
Our study is the ﬁrst demonstration in B. afzelii that immunization
with a given rOspC antigenprovided little or no cross-protection against
a strain carrying a different major ospC group allele. There are surpris-
ingly few studies showing the pattern of cross-protection of the anti-
OspC antibody response against strains carrying different major ospC
group alleles (Earnhart and Marconi, 2007a; Probert et al., 1997). The
study by Probert et al. (1997) demonstrated the absence of cross-
protection of the anti-OspC antibody response in B. burgdorferi s. s. by
showing that immunization with the rOspC antigen from strain
SON188 protected mice from homologous challenge but not heterolo-
gous challenge (strains CA4 and 297). Infection experiments that dem-
onstrate that mice can be sequentially infected with strains carrying
different major ospC group alleles also demonstrate the speciﬁcity
of the anti-OspC antibody response (Derdakova et al., 2004). More
generally, the observation that wild reservoir hosts are frequently in-
fectedwithmultiple ospC strains is further evidence that there is limited
cross-immunity between the major ospC groups (Anderson and Norris,
2006; Andersson et al., 2013b; Brisson and Dykhuizen, 2004; Perez
et al., 2011; Strandh and Raberg, 2015).
4.2. Limited cross-immunity favors strain A10 over strain A3We found evidence of some cross-protective acquired immunity be-
tween the two strains of B. afzelii. Previous studies on North American
strains of B. burgdorferi s. s. found no evidence of cross-protection
between rOspC antigens (Earnhart and Marconi, 2007a; Probert et al.,
1997). A recentﬁeld study suggested that cross-immunitywas structur-
ing the community of B. afzelii ospC strains in a population of wild
rodents (Andersson et al., 2013b). That study found a positive relation-
ship between the genetic distance between two major ospC groups and
their degree of association in the rodent host (Andersson et al., 2013b).
Our study found evidence of asymmetric cross-immunity because pre-
vious immune experience with rOspC type A10 protected 28.6% (2/7)
of the mice from infection with strain A3 but the reverse was not true.
Asymmetric cross-immunity gives the dominant strain a two-fold com-
petitive advantage over the weaker strain (Frank, 2002; Read and
Taylor, 2001). First, the dominant strain induces an acquired immune
response that blocks the weaker strain from super-infecting the same
host. Second, the dominant strain is not affected by cross-immunity
and is therefore capable of super-infecting hosts carrying the weaker
strain. The genetic distance between major ospC groups A3 and A10 is
intermediate (20.7%) with respect to the range of genetic distances
(8.9–26.4%) between other pairs of major ospC groups (Durand et al.,
2015). Thus the limited cross-protective immunity observed in this
months after the host-to-tick transmission event. A recent ﬁeld study
suggested that the innate immune system of the vertebrate reservoir
137M. Jacquet et al. / Infection, Genetics and Evolution 36 (2015) 131–140studymight exist for other pairs of major ospC groups. Whether the ob-
served cross-immunity effect also occurs under natural conditions re-
mains to be determined.
4.3.Mechanism of howOspC-speciﬁc antibodies protectmice from infection
The mechanism of how OspC-speciﬁc antibodies protect mice from
infection is not completely understood. We found that the immuniza-
tion treatment had no effect on the load of spirochetes inside the
blood-engorged challenge nymphs. This result is consistent with previ-
ous work showing that OspC-speciﬁc antibodies are not borreliacidal
inside the challenge nymphs (Gilmore et al., 1996). In contrast, OspA-
speciﬁc antibodies are known to reduce the prevalence and load of spi-
rochetes inside the tick vector (Fikrig et al., 1992). Expression of the
OspC protein is controlled during spirochete transmission from the
tick vector to the vertebrate host (De Silva and Fikrig, 1997; Tilly et al.,
2008). Following tick attachment to the host, the spirochetes in the
tick midgut start expressing OspC (Fingerle et al., 1998; Ohnishi et al.,
2001; Schwan and Piesman, 2000; Schwan et al., 1995). Some studies
suggest that OspC is critical for spirochetes tomigrate from the tickmid-
gut to the tick salivary glands (Fingerle et al., 2007; Pal et al., 2004).
Other studies have shown that OspC is critical for dissemination inside
the vertebrate reservoir host (Grimm et al., 2004; Seemanapalli et al.,
2010; Tilly et al., 2006). Gilmore et al. (1996) proposed that OspC-
speciﬁc antibodies could act in either the tick vector or the vertebrate
host to protect the latter from infection. The OspC-speciﬁc antibodies
can act inside the tick vector to block the migration of the spirochetes
from the tick midgut to the tick salivary glands (Gilmore and Piesman,
2000). Alternatively, the vertebrate immune system can kill the spiro-
chetes once they are injected into the host tissues by the tick vector.
Heterogeneous expression of theOspC protein suggests that spirochetes
will be targeted at different times during their transition from the tick
vector to the vertebrate host (Ohnishi et al., 2001) and so the twomech-
anisms are not mutually exclusive.
4.4. Acquired cross-immunity reduces spirochete load in xenodiagnostic
ticks
There was no effect of acquired cross-immunity on systemic (host-
to-tick) transmission (Fig. 1). In contrast, we found cross-reactive ac-
quired immunity effects on the tick spirochete load. The spirochete
load of the ticks that had fed on the infected heterologous mice was
two-fold lower than the ticks that had fed on the infected control
mice (Fig. 3). This result suggests that previous immune experience
with the OspC antigen allowed the heterologous mice to develop a
more effective antibody response, which ultimately reduced the spiro-
chete load inside the xenodiagnostic ticks, compared to the PBS-
immunized control mice. The OspC antigen is not believed to play an
important role in host-to-tick transmission because its expression is
generally suppressed inside the vertebrate reservoir host to facilitate
long-term persistence (Crother et al., 2004; Liang et al., 2004; Zhong
et al., 1997). However, the regulation of gene expression is not 100%
perfect (Gilmore and Piesman, 2000; Ohnishi et al., 2001) and OspC-
speciﬁc antibodies could clear any spirochetes that accidentally
expressed the OspC antigen. We found no effect of the immunization
treatment on mouse ear spirochete load suggesting that this infection
phenotype did not mediate the observed cross-immunity effect on
tick spirochete load. This result suggests that the OspC-speciﬁc antibod-
ies transmitted with the blood meal reduced the spirochete load inside
the tick vector. Previous work has shown that the spirochete load in-
creases inside the larval tick following the blood meal before declining
dramatically during the molt from larva to nymph (Piesman et al.,
1990). Given these dynamic changes in spirochete abundance, we
were surprised to ﬁnd an effect of the anti-OspC IgG antibodies twohost plays an important role in structuring the spirochete load inside
I. ricinus nymphs (Herrmann et al., 2013). The present study extends
this work by showing that the acquired immune system of the verte-
brate host can also inﬂuence the spirochete load inside I. ricinus.
Cross-immunity effects on tick spirochete load are only relevant if
they inﬂuence spirochete ﬁtness. Higher spirochete loadmight increase
the probability of spirochete persistence in the tick vector and/or the
probability of tick-to-host transmission in the next step of the Lyme dis-
ease life cycle. A recent study on I. scapularis ticks infected with
B. burgdorferi s. s. found that the proportion of infected ticks decreased
from 90% to 15% as the spirochete infection aged inside the ticks over
a period of six months under laboratory conditions (Voordouw et al.,
2013). In the present study, we found that the spirochete load of
B. afzelii decreased dramatically over a period of 6 months in the ﬂat
pre-challenge I. ricinus nymphs for both strains A3 (47.2% decrease)
and A10 (86.5% decrease). In contrast, the proportion of infected
nymphs over the same period was stable: from 90% to 70% for strain
A10 and from 77% to 80% for strain A3. Thus the spirochete population
declines over time inside the nymphal midgut under laboratory condi-
tions and future studies should investigate whether this phenomenon
occurs under natural conditions.
4.5. Mechanism underlying ﬁtness variation between strains of B. afzelii
We found a positive relationship between the spirochete load inside
themouse ear tissues and the systemic transmission rate (heterologous
mice in Fig. 2). A positive relationship between the spirochete load in
the mouse tissues and the probability of host-to-tick transmission
makes intuitive sense and was previously shown in a study on two spe-
cies of wild rodents (Raberg, 2012). Strains of B. afzelii are probably
under strong selection to maintain a high density in transmission-
relevant tissues like the skin of the ears where ticks are likely to feed
and acquire spirochetes.
Strain A10 outperformed strain A3 on the three infection pheno-
types. The mouse ear spirochete load, the systemic transmission rate,
and the spirochete load inside the ticks were 1.9, 1.2, and 1.34 times
higher for strain A10 than for strain A3. Interestingly, a ﬁeld study on
B. afzelii in populations of wild rodents and I. ricinus in Switzerland
found that A10 was one of the most common strains (Durand et al.,
2015; Perez et al., 2011; Tonetti et al., 2015). In a previous experimental
infection study, we estimated the reproductive number (R0) for six ospC
strains of B. afzelii including strains A3 and A10 (Tonetti et al., 2015).
This study showed that strain A10 had one of the highest R0 values,
which was 1.6 times higher than that of strain A3 (Tonetti et al.,
2015). The present study suggests that strain A10 is more successful
than strain A3 because it maintains a higher spirochete density in both
the rodent host and the tick vector. This study has therefore enhanced
our understanding of the mechanisms that determine variation in ﬁt-
ness between strains of B. afzelii (Tonetti et al., 2015). However, we em-
phasize that most of the phenotypic differences between strains A3 and
A10 are not necessarily caused by the ospC gene but by other loci that
are in linkage disequilibrium with the ospC locus (Brisson et al., 2012;
Bunikis et al., 2004; Hellgren et al., 2011; Qiu et al., 2004).
4.6. Speciﬁcity of the anti-OspC IgG response differs between OspC antigens
Infectionwith B. afzelii produced an anti-OspC IgG response thatwas
highly speciﬁc for that particular OspC antigen (Fig. S2; Supplementary
material). The OspC-speciﬁc IgG antibodies of the infected control mice
were 3.5–9.8 times more likely to bind the homologous rOspC antigen
than the heterologous rOspC antigen (Fig. S2). A previous study on
B. burgdorferi s. s. used a panel of seven rOspC proteins (major ospC
groups A, B, C, D, H, K, N) to show that the antiserum developed against
infection with one of three major ospC group strains (A, B, or D) was
speciﬁc for that particular rOspC protein (Earnhart et al., 2005). Interest-
ingly, B. afzelii strain A10 induced an OspC-speciﬁc IgG response that
in the strain-speciﬁc frequencies in the ﬁeld (Tonetti et al., 2015). Thus
there is hope that studies that ignore most of the interspeciﬁc diversity
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load in the mouse tissues that was almost twice as high as strain A3.
Thus one possible explanation is that the higher density of strain A10
in the mouse tissues induced a stronger OspC-speciﬁc IgG antibody re-
sponse. Another explanation for the difference in the strength of the
OspC-speciﬁc immune response is that strain A10 produces more
OspC on its surface than strain A3.
The structure of the OspC protein and the locations of the protective
epitopes are critical for understanding how the pattern of cross-
protective acquired immunity can inﬂuence the community structure
of B. afzelii ospC strains in the ﬁeld. The OspC protein is a dimer where
each monomer consists of ﬁve α-helices (α1, α2, α3, α4, α5) and two
β-strands (β1, β2) (Eicken et al., 2001; Kumaran et al., 2001). Most of
the variable regions are found on the β-strands and the two loops
(L4, L5) connecting helix α2 with α3 and helix α3 with α4. Earnhart
et al. (2005) found linear epitopes on the α5 helix (residues 168 to
203) and on loop 5 (residues 136 to 150) of the rOspC protein of
B. burgdorferi s. s. strain B31. Subsequent work showed that antibodies
developed against the α5 helix and loop 5 epitopes were bactericidal
(Earnhart et al., 2007). Gilmore andMbow (1999) using the same strain
found a conformational epitope involving either the N- or C-terminal of
the rOspC protein. Mathiesen et al. (1998) found one linear epitope
within the C-terminal seven residues of the OspC protein of Borrelia
garinii. Future studies should investigate whether the protective epi-
topes of the OspC antigen in B. afzelii are the same as the ones found
in B. burgdorferi s. s. and B. garinii.
The diversity of the ospC gene and the lack of cross-protection be-
tween the different OspC antigens complicate the development of an
OspC-based vaccine. In the United States, researchers have developed
amultivalent vaccine that combines the epitopes of up to eight different
OspC antigens (Earnhart et al., 2007; Earnhart and Marconi, 2007b).
However, an octavalent vaccine would not be sufﬁcient in Europe
where a single population of I. ricinus ticks can carry as many as 22 dif-
ferent major ospC group alleles (Durand et al., 2015). In addition, there
are concerns regarding the public interest in a Lyme disease vaccine
given the previous failure of the OspA-based Lymerix vaccine in the
United States (Embers and Narasimhan, 2013; Nardelli et al., 2009;
Plotkin, 2011). In summary, an OspC-based Lyme disease vaccine for
humans faces both technical and sociological hurdles.
4.7. The diversity and complexity of tick-borne infections in nature
The present experimental infection study is an oversimpliﬁcation of
the situation in nature. In the ﬁeld, infections withmultiple ospC strains
are common in both ticks and reservoir hosts (Andersson et al., 2013b;
Brisson and Dykhuizen, 2004; Durand et al., 2015; Heylen et al., 2014;
Perez et al., 2011; Strandh and Raberg, 2015; I.N. Wang et al., 1999).
The present study investigated indirect competition between ospC
strainsmediated by the host immune systembut did not consider direct
competition between strains over limited tick or host resources
(Derdakova et al., 2004; Strandh and Raberg, 2015). In addition to the
ospC strain diversity within a Borrelia genospecies, ticks and reservoir
hosts are often infected with multiple Borrelia genospecies (Gern
et al., 2010; Herrmann et al., 2013; Hovius et al., 2007; Perez et al.,
2011; Rauter and Hartung, 2005) and with different species of tick-
borne pathogens (Alekseev et al., 2003; Andersson et al., 2013a, 2014;
Burri et al., 2014; Levin and Fish, 2000). Mixed infections can result in
facilitation or inhibition where one pathogen strain or species has pos-
itive or negative effects on the transmission of another pathogen strain
or species (Ginsberg, 2008; Macaluso et al., 2002; Mixson et al., 2006).
The potential number of interactions betweenmultiple tick-borne path-
ogen strains and species is therefore overwhelming. However, a recent
study on the ospC strains of B. afzelii found that laboratory estimates of
strain ﬁtness could explain a surprisingly large amount of the variationof tick-borne pathogens can still shed light on the factors thatmaintain a
complex of pathogen strains (Tonetti et al., 2015).
5. Conclusions
In summary, our study found that acquired immunity against a given
OspC antigen provides limited cross-protection against B. afzelii strains
carrying a differentmajor ospC group allele. Cross-reactive acquired im-
munity in the vertebrate host inﬂuenced the spirochete load in ticks
that fed on those hostswith potentially important consequences for spi-
rochete persistence inside the tick vector and tick-to-host transmission.
The spirochete load in the rodent host inﬂuenced the probability of
host-to-tick transmission, thereby illuminating the mechanisms under-
lying the variation in ﬁtness between strains of B. afzelii.
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Abstract: 
Vector-borne pathogens use a diversity of strategies to evade the vertebrate immune 
system. Co-feeding transmission is a potential immune evasion strategy because the vector-
borne pathogen minimizes the time spent in the vertebrate host. We tested whether the Lyme 
disease pathogen, Borrelia afzelii, can use co-feeding transmission to escape the acquired 
immune response in the vertebrate host. We induced a strain-specific, protective antibody 
response by immunizing mice with one of two variants of OspC (A3 and A10), the highly 
variable outer surface protein C of Borrelia pathogens. Immunized mice were challenged via 
tick bite with B. afzelii strains A3 or A10 and infested with larval ticks at days 2 and 34 post-
infection to measure co-feeding and systemic transmission, respectively. Antibodies against a 
particular OspC variant significantly reduced co-feeding transmission of the targeted 
(homologous) strain but not the non-targeted (heterologous) strain. Cross-immunity between 
OspC antigens had no effect in co-feeding ticks but reduced the spirochete load two-fold in 
ticks infected via systemic transmission. In summary, OspC-specific antibodies reduced co-
feeding transmission of a homologous but not a heterologous strain of B. afzelii. Co-feeding 
transmission allowed B. afzelii to evade the negative consequences of cross-immunity on the 
tick spirochete load. 
 
Keywords: acquired immunity; Borrelia afzelii; co-feeding transmission; cross-immunity; 
Ixodes ricinus; Lyme borreliosis; outer surface protein C; spirochete load; tick-borne 
pathogen 
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INTRODUCTION 
Pathogens have evolved many strategies to avoid being cleared by the immune system 
of their hosts (Schmid-Hempel, 2008). Evasion of the host immune system is particularly 
important for vector-borne pathogens that establish long-lived systemic infections inside 
vertebrate hosts (Brunham et al., 1993). Many vector-borne pathogens use antigenic variation 
to stay one step ahead of the vertebrate antibody response (Bloom, 1979; Blaxter et al., 1992; 
Roberts et al., 1992; Damian, 1997; van der Woude and Baumler, 2004; Frank and Barbour, 
2006). Another strategy by which vector-borne pathogens can avoid the vertebrate immune 
system is to spend less time in the vertebrate host and more time in the arthropod vector. This 
strategy is most developed in vector-borne pathogens that are capable of co-feeding 
transmission. In co-feeding transmission, vector-borne pathogens are transmitted between 
infected and uninfected vectors feeding next to each other on the same vertebrate host at the 
same time (Randolph et al., 1996; Nuttall and Labuda, 2004; Tsao, 2009; Randolph, 2011; 
Voordouw, 2015). In systemic transmission by contrast, there is a latent phase during which 
the pathogen establishes a widespread (systemic) infection inside the vertebrate host before 
achieving host-to-vector transmission. Thus the main difference between co-feeding and 
systemic transmission is that the former is local and immediate whereas the latter is from 
anywhere on the host body and delayed (Randolph, 2011; Voordouw, 2015). These two 
modes of transmission are not exclusive and many vector-borne pathogens use both. Co-
feeding transmission has been reported in a variety of vector-borne pathogens including the 
vesicular stomatitis virus in black flies (Mead et al., 2000), the West Nile Virus in mosquitoes 
(Higgs et al., 2005), and a number of tick-borne pathogens including Thogoto virus (Jones et 
al., 1987), Bunyavirus (Labuda et al., 1997a), tick-borne encephalitis virus (TBEV) (Alekseev 
and Chunikhin, 1990; Labuda et al., 1993a; Labuda et al., 1993b; Labuda et al., 1993c), 
Anaplasma phagocytophilum (Levin and Fish, 2000), and Borrelia burgdorferi sensu lato (s. 
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l.), the species complex of tick-borne spirochete bacteria that includes the etiological agents of 
human Lyme disease (Gern and Rais, 1996; Sato and Nakao, 1997; Piesman and Happ, 2001; 
Crippa et al., 2002; Richter et al., 2002; Hu et al., 2003; Tonetti et al., 2015). 
Co-feeding transmission allows vector-borne pathogens to evade the innate and 
acquired immune system of their vertebrate hosts (Voordouw 2015). TBEV causes a short-
term viremia in mice that induces lifelong sterilizing immunity against future infection 
(Labuda et al., 1997b). However, rodents with acquired immunity against TBEV are still 
capable of transmitting the virus via co-feeding transmission (Labuda et al., 1997b). Thus co-
feeding transmission allows TBEV to evade the antibody response of resistant vertebrate 
hosts (Labuda et al., 1997b). Similarly, a study on the intracellular tick-borne bacterium, A. 
phagocytophilum, found that acquired immunity in rodents reduced but did not completely 
block co-feeding transmission (Levin and Fish, 2000). Co-feeding transmission also allows B. 
burgdorferi s. l. pathogens to obtain some fitness benefits from incompetent vertebrate hosts 
(Randolph et al., 1996; Gern et al., 1998; Voordouw, 2015). Ungulate hosts do not develop a 
systemic infection because their complement system kills Borrelia spirochetes (Kurtenbach et 
al., 1998a; Kurtenbach et al., 2002). However, a number of field studies suggest that deer and 
sheep can amplify Borrelia pathogens via co-feeding transmission (Kimura et al., 1995; 
Ogden et al., 1997; Pichon et al., 2000). Thus co-feeding transmission allows Borrelia 
pathogens to evade clearance by the hostile innate immune system of incompetent reservoir 
hosts (Voordouw, 2015). The purpose of the present study was to investigate whether the 
Lyme disease pathogen, B. afzelii, can use co-feeding transmission to evade pre-existing 
acquired immunity in the vertebrate host. 
Borrelia afzelii is one of the most common causes of Lyme disease in Europe 
(Piesman and Gern, 2004; Kurtenbach et al., 2006). This tick-borne spirochete bacterium is 
vectored by the hard tick Ixodes ricinus and the main reservoir hosts are wild rodents (Humair 
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et al., 1995; Humair and Gern, 1998; Kurtenbach et al., 1998b; Humair et al., 1999; 
Hanincova et al., 2003). Borrelia afzelii can establish long-lived infections in its rodent 
reservoir hosts with a high rate of systemic (host-to-tick) transmission (Gern et al., 1994; 
Humair et al., 1999). This tick-borne pathogen is also capable of co-feeding transmission 
(Gern and Rais, 1996; Crippa et al., 2002; Richter et al., 2002; Hu et al., 2003; Tonetti et al., 
2015). We have recently shown that there is genetic variation in the efficacy of co-feeding 
transmission among strains of B. afzelii suggesting that this trait can evolve under natural 
selection (Tonetti et al., 2015). In nature, rodent reservoir hosts are repeatedly exposed to 
infected ticks and studies in the United States have shown that wild rodent populations 
develop high levels of Borrelia-specific antibodies (Hofmeister et al., 1999; Bunikis et al., 
2004a). Under these circumstances, co-feeding transmission may allow Borrelia pathogens to 
escape acquired immunity in the rodent host (Voordouw, 2015). 
Acquired immunity in the vertebrate host plays an important role in the epidemiology 
of Lyme disease (Johnson et al., 1986a, b; Kurtenbach et al., 1994; Piesman et al., 1997; 
Liang et al., 2004). One Borrelia antigen that is particularly important for the pathogen’s 
interaction with the vertebrate immune system is outer surface protein C (OspC) (Radolf and 
Caimano, 2008). OspC is expressed during the transmission of Borrelia spirochetes from the 
tick vector to the vertebrate host (Schwan et al., 1995; Gilmore and Piesman, 2000; Grimm et 
al., 2004; Pal et al., 2004; Tilly et al., 2006; Fingerle et al., 2007). The single-copy ospC gene 
is highly polymorphic and this variability has likely evolved in response to the acquired 
immune system of the vertebrate host (Wang et al., 1999; Baranton et al., 2001). For the three 
Borrelia species that have been studied (B. burgdorferi s. s., B. afzelii, and B. garinii), the 
ospC alleles cluster into 14 to 22 major ospC groups, which are defined as > 8% divergent at 
the DNA sequence level from all other such groups (Wang et al., 1999; Baranton et al., 2001; 
Lagal et al., 2003; Brisson and Dykhuizen, 2004; Bunikis et al., 2004b; Durand et al., 2015; 
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Strandh and Raberg, 2015). Each OspC antigen induces a strong IgG antibody response that is 
protective against strains carrying that particular major ospC group allele (Preac-Mursic et al., 
1992; Probert and Lefebvre, 1994; Gilmore et al., 1996) but not against strains carrying 
different major ospC group alleles (Probert et al., 1997; Earnhart et al., 2005; Jacquet et al., 
2015). In nature, wild rodents and Ixodes ticks are often infected with multiple ospC strains of 
a given B. burgdorferi s. l. pathogen (Wang et al., 1999; Qiu et al., 2002; Brisson and 
Dykhuizen, 2004; Anderson and Norris, 2006; Pérez et al., 2011; Andersson et al., 2013; 
Durand et al., 2015; Strandh and Raberg, 2015). A recent study on B. afzelii suggested that 
cross-immunity between OspC antigens determined the pattern of multiple strain infections in 
wild rodents (Andersson et al., 2013). In summary, the OspC protein is a highly polymorphic 
immunodominant antigen that plays a key role in structuring the strain community of Borrelia 
pathogens in the field. 
In a previous study, we showed that immunization with recombinant OspC protein 
(rOspC) protected mice from a homologous infectious challenge with B. afzelii strains 
carrying the same major ospC group allele but not from a heterologous infectious challenge 
with B. afzelii strains carrying a different major ospC group allele (Jacquet et al., 2015). 
While there was no cross-immunity effect on systemic transmission, there was a cross-
immunity effect on the spirochete load in “systemic” ticks (i.e. ticks that had acquired the 
infection via systemic transmission). The purpose of the present study was to test whether co-
feeding transmission allowed B. afzelii to evade the negative effects of strain-specific 
antibodies developed against the homologous or the heterologous rOspC antigen. We 
predicted that co-feeding transmission would occur on the homologous mice but that 
transmission success would be reduced compared to the heterologous and control mice. We 
also predicted that the cross-immunity effect on the spirochete load in the “systemic” ticks, 
which depends on an enhanced secondary antibody response to B. afzelii infection, would not 
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occur in the co-feeding ticks. Co-feeding spirochetes evade this cross-immunity effect 
because transmission occurs before the secondary antibody response has time to develop. Of 
the two strains used in the immunization trial, strain A10 but not A3 is highly competent at 
co-feeding transmission (Tonetti et al., 2015). We chose these two strains to highlight that B. 
afzelii strains capable of co-feeding transmission have an important fitness advantage when 
faced with hosts that have protective, sterilizing antibodies. 
 
RESULTS 
Definitions: Mice that were immunized with a rOspC antigen that matched or did not 
match the major ospC group of the subsequent challenge strain are referred to as 
“homologous” or “heterologous” mice, respectively. Larval ticks that had the opportunity to 
acquire the B. afzelii infection via co-feeding or systemic transmission and then molted into 
nymphs are referred to as “co-feeding” or “systemic” ticks, respectively. 
Prevalence of B. afzelii in co-feeding challenge nymphs: There was no evidence for 
co-feeding transmission among the blood-engorged challenge nymphs. For strain A3, the 
prevalence of infection in the blood-engorged challenge nymphs was similar between the 
control (58.8% = 20/34), heterologous (62.1% = 18/29), and homologous (53.4% = 31/58) 
groups. For strain A10, the prevalence of infection in the blood-engorged challenge nymphs 
was also similar between the control (55.3% = 21/38), heterologous (54.4% = 31/57), and 
homologous (72.5% = 37/51) groups. There was no effect of immunization treatment (GLM: 
 df = 1,  2 = 0.972, p = 0.615), strain (GLM:  df = 1,  2 = 0.608, p = 0.436), and their 
interaction (GLM:  df = 2,  2 = 4.225, p = 0.121) on the proportion of blood-engorged 
challenge nymphs that were infected with B. afzelii. 
Correspondence between mice that had co-feeding and systemic transmission: There 
was a statistically significant association between the two modes of transmission across the 40 
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mice (2 = 4.812, df = 1, p = 0.028). Sixteen mice had both modes of transmission and 12 
mice had neither. There were 5 homologous mice that had co-feeding but no systemic 
transmission: two challenged with strain A3 and three challenged with strain A10. There were 
7 B. afzelii-infected mice that had systemic but no co-feeding transmission: six infected with 
strain A3 (three control, three heterologous) and one infected with strain A10 (heterologous).  
Antibodies against rOspC reduced the mouse-specific co-feeding transmission rate: 
There was no difference in the mouse-specific co-feeding transmission rate between the 
control and heterologous mice (GLM:  df = 2,  2 = 0.24, p = 0.889; Figure 1) and these 
two groups were therefore combined (Table 1). In contrast, there was a highly significant 
difference in the mouse-specific co-feeding transmission rate between the homologous mice 
and the combined group of control and heterologous mice (GLM:  df = 1,  2 = 83.74, p < 
0.001; Figure 1). For strain A10, the co-feeding transmission rate of the control and 
heterologous mice combined (51.6% = 98/190 ticks; 13 mice; Table 1) was 15.6 times higher 
than the homologous mice (3.3% = 3/90 ticks; 7 mice; Table 1). For strain A3, the co-feeding 
transmission rate of the control and heterologous mice combined (11.1% = 14/126 ticks; 12 
mice; Table 1) was 6.2 times higher than the homologous mice (1.8% = 2/111 ticks; 8 mice; 
Table 1). Thus in both strains, co-feeding transmission was drastically reduced but not 
completely eliminated by antibodies directed against the homologous but not the heterologous 
rOspC antigen. 
There was also a significant effect of B. afzelii strain on the mouse-specific co-feeding 
transmission rate (GLM:  df = 1,  2= 58.16, p < 0.001; Figure 1). For the control and 
heterologous mice combined (n = 25), the co-feeding transmission rate of strain A10 (51.6% 
= 98/190 ticks; summed over 5 control and 8 heterologous mice; Table 1) was 4.6 times 
higher than that of strain A3 (11.1% = 14/126 ticks; summed over 5 control and 7 
heterologous mice; Table 1). 
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Efficacy of co-feeding versus systemic transmission: Larval ticks were more likely to 
acquire spirochetes via systemic transmission than co-feeding transmission. For strain A10, 
systemic transmission (90.7% = 118/130; summed over 5 infected control and 8 infected 
heterologous mice) was 1.75 times higher than co-feeding transmission (51.6% = 98/190) and 
this difference was statistically significant (paired t-test: t = 4.67, df = 12, p < 0.001). For 
strain A3, systemic transmission (75% = 75/100; summed over 5 infected control and 5 
infected heterologous mice) was 5.8 times higher than co-feeding transmission (13.3% = 
14/105) and this difference was statistically significant (paired t-test: t = 8.58, df = 9, p < 
0.001). Thus systemic transmission was more efficient than co-feeding transmission for both 
strains. 
Effect of co-feeding versus systemic transmission on the tick spirochete load: Nymphs 
infected as larvae via co-feeding transmission had significantly lower spirochete loads than 
nymphs infected as larvae via systemic transmission (analysis was restricted to the subset of 
mice that had both modes of transmission for strain A10 (n = 12); paired t-test: t = 3.30, df = 
11, p = 0.007; Figure 2). For the control mice (n = 5), the spirochete load of the systemic ticks 
(32,557 ± 4,590 spirochetes per nymph) was 6.1 times higher than the co-feeding ticks (5,337 
± 1,221 spirochetes per nymph). For the heterologous mice (n = 7), the spirochete load of the 
systemic ticks (16,809 ± 3,133 spirochetes per nymph) was 1.9 times higher than the co-
feeding ticks (8,940 ± 2,267 spirochetes per nymph). There was no difference in the 
spirochete load of co-feeding ticks between control and heterologous mice (independent 
samples t-test: t = 1.52, df = 10, p = 0.161). 
Correlations between co-feeding transmission rate, systemic transmission rate, co-
feeding tick spirochete load, and the systemic tick spirochete load: None of the six pairwise 
correlations were statistically significant between the following four variables: the co-feeding 
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transmission rate, the systemic transmission rate, the co-feeding tick spirochete load, and the 
systemic tick spirochete load (Table S1).  
 
DISCUSSION 
OspC-antibodies reduced co-feeding transmission of B. afzelii: OspC-specific 
antibodies in laboratory rodents greatly reduced the efficacy of co-feeding transmission of the 
homologous but not the heterologous strain of B. afzelii. For strain A10, immunization with 
the homologous rOspC A10 antigen reduced the co-feeding transmission rate 15-fold 
compared to the control and heterologous groups. There were a number of homologous mice 
that infected larval ticks via co-feeding transmission despite being protected from systemic 
infection. This important result shows that co-feeding transmission can occur independently 
from and is not inevitably followed by systemic infection. However, the co-feeding 
transmission rate of B. afzelii on these homologous mice was so low that this strategy is 
unlikely to make a significant contribution to pathogen fitness (Hartemink et al., 2008). Other 
studies have shown that acquired immunity in the vertebrate host can reduce the efficacy of 
co-feeding transmission of tick-borne pathogens (Jones and Nuttall, 1989; Labuda et al., 
1997b; Levin and Fish, 2000). For the tick-borne bacterium A. phagocytophilum, acquired 
immunity reduced the co-feeding transmission rate ten-fold (10.8% versus 1.1%) in a natural 
rodent host (Levin and Fish, 2000). For TBEV, acquired immunity reduced the co-feeding 
transmission rate three-fold (72% versus 24%) in field mice and 1.4-fold (42% versus 29%) in 
bank voles (Labuda et al., 1997b). Finally, acquired immunity against the Thogoto virus in 
guinea pigs completely eliminated co-feeding transmission (Jones and Nuttall, 1989). Thus 
acquired immunity in the vertebrate host generally reduces co-feeding transmission of vector-
borne pathogens but there is substantial variation in the magnitude of the effect size. In 
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summary, co-feeding transmission did not allow B. afzelii to escape the protective strain-
specific antibody response of the vertebrate host. 
Co-feeding transmission allows B. afzelii to escape the negative effects of cross-
immunity on tick spirochete load: Cross-reactive acquired immunity (or cross-immunity) 
refers to differences in infection phenotype between the heterologous and control groups. 
Heterologous mice had previous experience with a different (heterologous) OspC antigen 
whereas control mice were completely naïve at the time of the infectious challenge. Our study 
found no effects of cross-immunity on the co-feeding transmission rate or on the co-feeding 
tick spirochete load (Figures 1 and 2). By contrast, we showed in a previous study that there 
were strong effects of cross-immunity on the spirochete load of both strains in “systemic” 
ticks (Jacquet et al., 2015). The mean spirochete load of the systemic ticks that had fed on the 
infected heterologous mice was half that of the systemic ticks that had fed on the infected 
control mice (Jacquet et al., 2015). This result suggests that previous immune experience with 
a different OspC antigen allowed the heterologous mice to develop a faster secondary 
antibody response against the B. afzelii infection than the control mice. The efficacy of this 
secondary antibody response would have peaked at three to four weeks after the infectious 
challenge, which is when the mice were infested with the second batch of larval ticks to 
measure systemic transmission. In contrast, co-feeding transmission was measured 48 hours 
after the infectious challenge, which was not sufficient time for the heterologous mice to 
develop the enhanced secondary antibody response. Thus the difference in timing between co-
feeding and systemic transmission explains the difference in the cross-immunity effect on tick 
spirochete load between these two modes of transmission. Co-feeding transmission is 
instantaneous and therefore escapes the negative consequences of the cross-immunity-
enhanced secondary antibody response, which is time-lagged. Systemic transmission is 
delayed and is therefore vulnerable to this time-lagged, cross-immunity-enhanced secondary 
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antibody response. In summary, co-feeding transmission allowed B. afzelii to evade the 
negative effects of cross-immunity on tick spirochete load. 
The mechanism of co-feeding transmission: The mechanism of co-feeding 
transmission in Borrelia pathogens is not well understood (Voordouw, 2015). During the 
blood meal, infected nymphs inoculate about 100 spirochetes into the feeding lesion (Kern et 
al., 2011). These spirochetes replicate locally around the site of the tick bite before 
disseminating to other host tissues (Shih et al., 1992; Hodzic et al., 2003). Larval ticks 
attached near the feeding lesion of infected nymphal ticks could subsequently imbibe these 
locally replicating spirochetes (Randolph et al., 1996; Tsao, 2009) . A study on B. afzelii in 
laboratory mice showed that co-feeding transmission has both a spatial and a temporal 
component (Richter et al., 2002). Co-feeding transmission was most efficient (55.3%) when 
the larvae fed in close proximity (< 1 cm) to the nymphs and when the larval ticks attached 
two to three days after the nymphs (Richter et al., 2002). Previous studies have shown that 
nymph-to-host transmission of B. afzelii increases over time and reaches ~100% after 48 
hours (Kahl et al., 1998; Crippa et al., 2002). This time delay in nymph-to-host transmission 
is caused by the migration of the B. afzelii spirochetes from the tick midgut to the tick salivary 
glands. The duration of this spirochete migration explains why co-feeding transmission is 
highest when the larvae attach >48 hours after the nymphs (Richter et al., 2002). 
The saliva of ticks is believed to play an important role in the co-feeding transmission 
of tick-borne pathogens (Nuttall and Labuda, 2004). Tick saliva contains substances that 
modulate the inflammatory and immune response of the vertebrate host (Ribeiro et al., 2006; 
Bowman and Nuttall, 2008; Kazimirova and Stibraniova, 2013). For example, tick saliva 
inhibits or interferes with the vertebrate complement response (Lawrie et al., 1999; Lawrie et 
al., 2005), the activity of chemokines and cytokines (Hajnicka et al., 2001; Brossard and 
Wikel, 2004; Hajnicka et al., 2005), and macrophage function (Kopecky and Kuthejlova, 
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1998). The immunosuppressive properties of tick saliva help tick-borne pathogens, including 
B. burgdorferi s. l., to evade the host immune system (Kuthejlova et al., 2001; Ramamoorthi 
et al., 2005). Tick salivary glands also contain substances that stimulate spirochete growth in 
vitro (Rudolf and Hubalek, 2003; Rudolf et al., 2010) and in laboratory mice (Zeidner et al., 
2002; Macháčková et al., 2006). In summary, we expected that co-feeding ticks inside the 
capsule would create a local immunosuppressed environment in the rodent skin that is 
propitious for spirochete replication and transmission. However, this local 
immunosuppression was not sufficient to suppress the protective capacity of the OspC-
specific antibodies. 
Protection of OspC-specific antibodies: The mechanism by which the OspC-specific 
antibodies reduced co-feeding transmission is not completely understood. Borrelia 
spirochetes express OspC during their migration from the tick midgut to the tick salivary 
glands (Schwan et al., 1995; De Silva and Fikrig, 1997). There is some controversy regarding 
the functional role of the OspC protein during tick-to-host transmission (Radolf and Caimano, 
2008). Some studies suggest that the OspC protein allows the Borrelia spirochetes to invade 
the salivary glands of Ixodes ticks (Pal et al., 2004; Fingerle et al., 2007). However, the 
research by Rosa and colleagues shows that the OspC protein allows the spirochete to 
disseminate from the site of the tick bite and establish infection inside the vertebrate host 
(Grimm et al., 2004; Stewart et al., 2006; Tilly et al., 2006; Tilly et al., 2008; Seemanapalli et 
al., 2010; Kenedy et al., 2012). Thus OspC-specific antibodies can target spirochetes in either 
the tick vector or the vertebrate host (Gilmore et al., 1996; Gilmore and Piesman, 2000). 
Regardless of the underlying mechanism, the present study clearly shows that OspC-specific 
antibodies reduce co-feeding transmission of homologous strains of B. afzelii carrying the 
same major ospC group allele. 
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Co-feeding transmission among nymphs: The results do not allow us to conclude 
whether co-feeding transmission occurs between nymphs or not. In the present study, we 
found no effect of the immunization treatment on the proportion of infected nymphs, which 
suggests that co-feeding transmission did not occur between nymphs. However, the blood-
engorged nymphs were frozen immediately after dropping off the host. Hence, a likely 
explanation is that any spirochetes transmitted by co-feeding between nymphs did not have 
enough time to replicate to a detectable abundance. In contrast, an experimental infection 
study on songbirds that allowed blood-engorged nymphs to molt into adults showed that 
nymphs can acquire Borrelia pathogens via co-feeding transmission (Heylen et al., 2014). 
Regardless of its existence or not, theoretical models have shown that nymph-to-nymph co-
feeding transmission makes a negligible contribution to the reproductive number (R0) of 
Borrelia pathogens (Hartemink et al., 2008; Harrison et al., 2011; Harrison and Bennett, 
2012). Thus from an epidemiological perspective, nymph-to-larva co-feeding transmission is 
much more important than nymph-to-nymph transmission (Voordouw, 2015). 
The mode of transmission and tick spirochete load: The spirochete load in co-feeding 
nymphs was up to six times lower than in systemic nymphs two months after the larval blood 
meal (Figure 2). This result suggests that larval ticks acquire fewer spirochetes via co-feeding 
transmission than systemic transmission and/or that co-feeding spirochetes are not able to 
increase their growth rate to reach the same population size as spirochetes acquired via 
systemic transmission. A study on B. burgdorferi s. s. in I. scapularis has shown that the 
spirochete population is highly dynamic during this period (Piesman et al., 1990). The 
spirochete population grows rapidly after the blood meal and then declines dramatically 
during the larva-to-nymph molt (Piesman et al., 1990). The detection of spirochetes after the 
larva-to-nymph molt is therefore proof of transstadial transmission and that the nymph 
contains a viable population of spirochetes (Richter et al., 2002; Heylen et al., 2014). 
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Additional evidence of the viability of co-feeding spirochetes comes from studies that have 
cultured spirochetes from co-feeding ticks (Piesman and Happ, 2001; Hu et al., 2003). 
Whether ticks infected via co-feeding transmission are capable of infecting competent 
reservoir hosts is currently unknown and should be addressed in future research (Voordouw, 
2015). 
Strain-specific differences in co-feeding transmission and fitness: There were strain-
specific differences in the efficacy of co-feeding transmission (Table 1). The co-feeding 
transmission rate of strain A10 was 4.6 times higher than strain A3 confirming our previous 
study (Tonetti et al., 2015). The rate of systemic transmission of strain A10 is also higher than 
strain A3 (Jacquet et al., 2015; Tonetti et al., 2015). We recently used next generation 
matrices to estimate the reproductive number (R0) for six different ospC strains of B. afzelii 
(Tonetti et al., 2015). This analysis found that strain A10 had one of the highest R0 values, 
which was 1.6 times higher than that of strain A3 (Tonetti et al., 2015). This strain-specific 
difference in fitness is associated with strain-specific differences in spirochete load in both the 
vertebrate host and the tick vector. Compared to strain A3, the spirochete load of strain A10 is 
1.9 times higher in the mouse tissues and 1.34 times higher in systemic nymphs (Jacquet et 
al., 2015). These results suggests that strain A10 has higher co-feeding and systemic 
transmission success than strain A3 because it establishes a higher spirochete load in the 
mouse tissues. Importantly, the strain-specific differences in co-feeding and systemic 
transmission success were not caused by differences in the infectious challenge because the 
prevalence of infection in the challenge nymphs was the same between strains A3 and A10, 
both before and after the infectious challenge.  
Contribution of co-feeding transmission to fitness of B. afzelii: The importance of co-
feeding transmission to Borrelia pathogens is controversial (Richter et al., 2002; Randolph 
and Gern, 2003; Richter et al., 2003; Voordouw, 2015). Theoretical models suggest that co-
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feeding transmission makes a modest contribution to the reproductive number of Borrelia 
pathogens and is not necessary for the maintenance of Lyme disease in nature (Hartemink et 
al., 2008; Harrison et al., 2011; Harrison and Bennett, 2012). However, these models ignore 
the reality that Borrelia infections in the vertebrate host and the tick vector frequently consist 
of multiple strains (Wang et al., 1999; Qiu et al., 2002; Brisson and Dykhuizen, 2004; 
Anderson and Norris, 2006; Pérez et al., 2011; Andersson et al., 2013; Durand et al., 2015; 
Strandh and Raberg, 2015). A recent study showed that B. afzelii ospC strains compete with 
each other inside wild rodent reservoir hosts although the underlying mechanism remains 
unknown (Strandh and Raberg, 2015). Studies on other vector-borne diseases, namely rodent 
malaria, have demonstrated that competition between parasite strains inside the rodent host is 
common and can influence host-to-vector transmission success (de Roode et al., 2005; Bell et 
al., 2006; Alizon et al., 2013). Assuming that competition exists in multiple-strain infections 
of B. afzelii, strains capable of co-feeding transmission may have an important competitive 
advantage over strains that are not capable of this mode of transmission.  
Previous authors have suggested that co-feeding may allow Borrelia pathogens to 
obtain some transmission on vertebrate hosts that are otherwise refractory to systemic 
infection (Randolph et al., 1996; Gern et al., 1998). A recent field study suggested that co-
feeding transmission enhances the diversity of ospC strains in B. afzelii (Pérez et al., 2011). 
The authors speculated that some ospC strains are better at the classic lifecycle (systemic 
infection followed by systemic transmission) whereas other strains are better at co-feeding 
transmission (Pérez et al., 2011). However, in a recent experimental infection study on six 
different ospC strains of B. afzelii, we found no such trade-off between co-feeding 
transmission and systemic transmission (Tonetti et al., 2015). Instead, strains with high co-
feeding transmission also had high systemic transmission, and these strains had the highest 
values of R0 (Tonetti et al., 2015). Borrelia afzelii ospC strains with high co-feeding 
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transmission (and thus a high value of R0) were also the most common strains in a local 
population of I. ricinus ticks over a period of 11 years (Pérez et al., 2011; Durand et al., 
2015). Thus co-feeding transmission is correlated with spirochete phenotypes that lead to high 
fitness in mice and high frequency in tick populations in nature. 
 
CONCLUSIONS 
OspC-specific antibodies in the vertebrate host reduced the efficacy of co-feeding 
transmission of a homologous but not a heterologous strain of B. afzelii. Immunization with a 
heterologous OspC antigen had no effect on co-feeding transmission compared to naive 
control mice. While co-feeding transmission occurred in homologous mice that were 
protected from systemic infection, the efficacy was too low to make an epidemiologically 
relevant contribution to the fitness of B. afzelii. Thus Borrelia pathogens cannot use co-
feeding transmission to evade host antibodies specific for their OspC antigen. However, in 
comparison with systemic transmission, co-feeding transmission did allow B. afzelii to evade 
the negative consequences of the secondary antibody response on tick spirochete load. The 
two strains of B. afzelii (A3 and A10) differed almost five-fold in their efficacy of co-feeding 
transmission. Co-feeding ticks had a spirochete load that was six times lower than systemic 
ticks. Future studies should investigate whether these co-feeding ticks are infectious to 
vertebrate hosts. 
 
MATERIALS AND METHODS 
Immunization trial: We used an immunization trial followed by infectious challenge 
via tick bite to test whether OspC-specific antibodies in laboratory rodents blocked co-feeding 
transmission of B. afzelii. The details of this immunization trial were previously described in 
Jacquet et al. (2015). Briefly, BALB/c mice were immunized with adjuvant and one of two 
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different recombinant OspC (rOspC) proteins: rOspC A3 (n = 16 mice) and rOspC A10 (n = 
16 mice). The control mice were immunized with phosphate-buffered solution (PBS) and 
adjuvant (n = 10 mice). Mice were subsequently challenged via tick bite with one of two B. 
afzelii strains that carried either the A3 or A10 major ospC group allele (hereafter referred to 
as strain A3 and strain A10). Thus there were six combinations of antigen (rOspC A3, rOspC 
A10, PBS) and infectious challenge (strain A3, strain A10). In what follows, the terms 
homologous and heterologous refer to whether the major ospC allele of the challenge strain 
matched the rOspC antigen or not (see Table 1). One of the mice belonging to the rOspC 
A10/strain A3 group died during the experiment so that the final sample size was 41 mice. 
These 41 mice were distributed as follows: rOspC A3-immunized mice challenged with strain 
A3 (homologous; n = 8), rOspC A3-immunized mice challenged with strain A10 
(heterologous; n = 8), rOspC A10-immunized mice challenged with strain A3 (heterologous; 
n = 7), rOspC A10-immunized mice challenged with strain A10 (homologous; n = 8), control 
mice challenged with strain A3 (n = 5), and control mice challenged with strain A10 (n = 5).  
In a previous study, Jacquet et al. (2015) showed that the 16 homologous mice were 
protected from the infectious challenge whereas the 10 control mice became infected with B. 
afzelii. Two of the mice immunized with rOspC A10 were protected from infection with strain 
A3 whereas the remaining 13 heterologous mice became infected with B. afzelii. Thus there 
were 23 mice that became infected with B. afzelii: 5 heterologous mice with strain A3, 8 
heterologous mice with strain A10, 5 control mice with strain A3, and 5 control mice with 
strain A10. The systemic infection status of all 41 mice was determined using three 
independent criteria: (1) IgG antibody response against the VlsE antigen (blood sample taken 
21 days after infectious challenge), (2) qPCR of mouse ear tissue biopsy (taken 34 days after 
infectious challenge), and (3) qPCR of xenodiagnostic ticks (larval ticks were fed on mice 34 
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days after infectious challenge). The correspondence between these three independent 
measures of systemic infection with B. afzelii was 100% (Jacquet et al., 2015). 
Creation of nymphs infected with B. afzelii ospC strains A3 and A10: The creation of 
the infected nymphs used in the infectious challenge (hereafter the “challenge” nymphs) was 
previously described in Jacquet et al. (2015). Briefly, 50–100 larval ticks from our pathogen-
free I. ricinus colony were fed on each of ten BALB/c mice that had been previously infected 
via nymphal tick bite with either strain A3 or strain A10. Blood-engorged larval ticks were 
placed in individual tubes and allowed to molt into the challenge nymphs. For each of the ten 
mice, we randomly sampled four challenge nymphs and tested them for B. afzelii infection 
using qPCR. The mean proportion of infected challenge nymphs for strain A3 was 80.0% 
(16/20; 95% confidence interval = 55.7–93.4%) and for strain A10 was 70.0% (14/20; 95% 
confidence interval = 45.7–87.2%). The remaining challenge nymphs were used in the 
infectious challenge of the rOspC-immunized and control mice (see below). 
Co-feeding transmission assay: With respect to the purpose of the present study, B. 
afzelii strains A3 and A10 were chosen because they differ in the efficacy of co-feeding 
transmission. Strain A10 has high co-feeding transmission (66.2%) whereas strain A3 has low 
co-feeding transmission (0.0%) (Tonetti et al., 2015). The infectious challenge consisted of 
infesting each mouse with ten B. afzelii-infected challenge nymphs (Jacquet et al., 2015), 
which had been randomly selected from a pool of nymphs for which the infection rate of 
strain A3 (80.0%) and strain A10 (70.0%) was known (see above). These challenge nymphs 
were placed in a plastic capsule that was glued to the backs of the mice to prevent the nymphs 
from escaping (Jacquet et al., 2015). To measure co-feeding transmission, mice were infested 
with 80 larval ticks at 48 hours after the nymphal infestation. To enhance co-feeding 
transmission, the larvae were placed in the same capsule as the nymphs and the mice were 
anesthetized with isoflurane during this procedure. The larvae were introduced through a 
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small hole in the capsule surface that was covered with tape for 48 hours to prevent the ticks 
from escaping. All nymphal and larval ticks in the capsules were allowed to feed to repletion. 
Infested mice were placed in individual cages that facilitated the collection of blood-engorged 
ticks. Blood-engorged nymphs were frozen at –20°C and tested for B. afzelii using qPCR to 
confirm that each mouse had been infested with at least one infected challenge nymph 
(Jacquet et al., 2015). Blood-engorged larvae were placed in individual tubes and were 
allowed to molt into nymphs. These tubes were stored at room temperature with high 
humidity to avoid tick dehydration. Four weeks after molting, the nymphs were frozen at –
20°C. One month after the infectious challenge, all the mice were infested with a batch of 50 
to 100 xenodiagnostic larvae to measure systemic (host-to-tick) transmission (Jacquet et al., 
2015). The nymphs infected as larvae via systemic transmission were processed the same way 
as the nymphs infected as larvae via co-feeding transmission. These two types of nymphs will 
hereafter be referred to as co-feeding ticks and systemic ticks. For each mouse, we analyzed a 
maximum of 20 co-feeding ticks and 10 systemic ticks. 
DNA extraction and qPCR to test ticks for spirochete infection: DNA extraction of all 
the ticks was performed following a protocol described by Jacquet et al. (2015). A 
quantitative PCR amplifying a 132 base pair fragment of the flagellin gene was used to detect 
and quantify Borrelia DNA following a protocol described by Jacquet et al. (2015). Each 
qPCR plate contained 28 samples, 3 standards (that also functioned as positive controls), and 
one negative control (all run in triplicate) for a total of 96 qPCR reactions (see Jacquet et al. 
(2015) for details). 
 
STATISTICAL METHODS 
Effect of rOspC immunization on the mouse-specific co-feeding transmission rate: The 
co-feeding transmission rate was calculated for each mouse for which we recovered at least 
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one co-feeding larval tick (mean = 13.9, range = 2–20). There was one mouse for which we 
did not recover any co-feeding larval ticks so the final sample size was 40 mice. A 
generalized linear model (GLM) with binomial errors was used to test whether immunization 
treatment, B. afzelii ospC strain, and their interaction had an effect on the mouse-specific co-
feeding transmission rate. Model simplification was used to test whether the control and 
heterologous mice could be combined into a single group. 
Efficacy of co-feeding versus systemic transmission: The mouse-specific rates of co-
feeding and systemic transmission represent paired data. A paired t-test was therefore used to 
determine whether co-feeding transmission was less efficient than systemic transmission for 
the subset of infected mice (n = 23 mice).  
Calculation of the nymphal tick spirochete load: The spirochete load refers to the 
number of spirochetes in the nymph at four weeks after the larva-to-nymph molt (when the 
nymph was killed by freezing). The spirochete load of each nymphal tick was calculated as 
the geometric mean of the three replicate runs by the Roche software (negative runs were 
excluded). Similarly, the average nymphal tick spirochete load for each mouse was calculated 
as the geometric mean of the ticks that had acquired the infection after feeding on that mouse 
(negative ticks were excluded). The estimates of tick spirochete load were calculated 
separately for the co-feeding ticks and the systemic ticks. We had previously shown that the 
spirochete load in the systemic ticks is a highly repeatable phenotype (Jacquet et al., 2015). 
Effect of co-feeding versus systemic transmission on the tick spirochete load: The 
geometric mean spirochete load of the infected co-feeding ticks and of the infected systemic 
ticks was calculated for a subset of 16 infected mice that had both modes of transmission. The 
analysis was subsequently restricted to the 12 mice infected with strain A10 because only 4 
mice were infected with strain A3. A paired t-test was used to determine whether the 
spirochete load of the co-feeding ticks was different from the spirochete load of the systemic 
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ticks. An independent two-sample t-test was used to test whether the immunization treatment 
affected the spirochete load in the co-feeding ticks. 
Correlations between co-feeding transmission rate, systemic transmission rate, co-
feeding tick spirochete load, and systemic tick spirochete load: The six pairwise correlations 
between the co-feeding transmission rate (proportion of ticks infected via co-feeding 
transmission), the systemic transmission rate (proportion of ticks infected via systemic 
transmission), the log-transformed spirochete load in ticks infected via co-feeding 
transmission, and the log-transformed spirochete load in ticks infected via systemic 
transmission, were calculated separately for strain A3 (n = 4 mice) and strain A10 (n = 12 
mice) and for both strains combined (n = 16). These tests were done on the subset of 
systemically infected mice that produced at least one tick infected via co-feeding transmission 
(n = 16 mice). 
All statistical analyses were done in R version 3.2.0. (R Development Core Team, 
2009). 
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TABLES 
 
Table 1. The rate of co-feeding transmission is shown for the six combinations of the antigen 
used for immunization (rOspC A3, rOspC A10 or PBS) and the B. afzelii ospC strain used in 
the infectious challenge (A3 or A10).  
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FIGURES 
 
Figure 1. Co-feeding transmission of B. afzelii was blocked by the homologous but not the 
heterologous immunization treatment. There was no difference in co-feeding transmission 
between the heterologous and control group. The rate of co-feeding transmission of strain 
A10 was almost five times higher than that of strain A3. The unit of replication is the mouse-
specific co-feeding transmission rate. The sample size includes all the mice from which we 
recovered co-feeding larval ticks (n = 40). Shown are the means and the standard errors. 
 
Figure 2. The mode of transmission (co-feeding or systemic) influenced the spirochete load 
of B. afzelii ospC strain A10 inside I. ricinus nymphal ticks. Nymphs infected as larvae via 
systemic transmission had a higher spirochete load than nymphs infected as larvae via co-
feeding transmission. The effect of the immunization treatment (control versus heterologous) 
depended on the mode of transmission. For the co-feeding nymphs, the immunization 
treatment had no effect on the tick spirochete load. For the systemic nymphs, immune 
experience with the heterologous rOspC antigen reduced the tick spirochete load relative to 
the control group (Jacquet et al., 2015). The unit of replication is the mouse-specific 
geometric mean spirochete load. The sample size is the subset of systemically infected mice 
that produced at least one A10-infected tick via co-feeding transmission (n = 12). Shown are 
the means and the standard errors. 
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Figure 1.  
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Figure 2. 
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Abstract: 
The development of an infection in a susceptible host can depend on the number of infective 
pathogen cells. In vector-borne diseases, blood-sucking arthropods (e.g. ticks, mosquitoes) 
transmit the pathogen to the host during the blood meal. For the Lyme disease pathogen, 
Borrelia afzelii, a spirochete bacterium transmitted by the sheep tick (Ixodes ricinus), we 
tested whether the age of infection in the host, the age of infection in the vector, and the strain 
of the pathogen had an influence on host-to-tick transmission and tick spirochete load. Mice 
infected via tick bite with one of two strains of B. afzelii (A3 or A10) were infested with 
larval ticks 1, 2, 3, and 4 months post-infection. Those ticks were then analyzed 1 and 4 
months after larva-to-nymph molt. Host-to-tick transmission was highest at 1 month post-
infection and remained high and stable for the remaining three months. Nymphal aging 
reduced the Borrelia spirochete load in nymphal ticks by a factor of 6.3 to 15.3 over a period 
of three months. In contrast, nymphal ageing did not influence the probability of detecting the 
spirochete infection in nymphal ticks. Our study shows that two common strains of B. afzelii 
can persist in rodents over long periods of time and that vector ageing may have important 
consequences for the fitness of vector-borne pathogens.  
 
Keywords: Borrelia afzelii; Ixodes ricinus; outer surface protein C; systemic transmission; 
bacterial load. 
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INTRODUCTION 
Pathogens encounter many critical steps during their life cycle. In vector-borne 
diseases, the arthropod vector facilitates the step of finding a suitable host for the vector-borne 
pathogen. During the blood meal, the arthropod vector (e.g. ticks or mosquitoes) helps the 
pathogen to cross the defensive barrier of the skin. The pathogen will then establish an 
infection in the vertebrate host that facilitates transmission to new naïve vectors. One of the 
key factors in this life cycle is the number or dose of pathogen cells that is transmitted to the 
vertebrate host (Schmid-Hempel 2008). 
The infectious dose can vary greatly among vector-borne pathogens. For some 
mosquito-borne pathogens such as dengue virus, the infective cells are directly injected at the 
moment of the blood meal (Rosenberg et al. 1990). In contrast, vector-to-host transmission is 
delayed (~ 24 hours) for the tick-borne spirochete bacterium Borrelia burgdorferi sensu lato 
because the pathogen has to migrate from the tick midgut to the salivary glands during the 
blood meal (Piesman and Gern 2004). The probability that the spirochete will infect the 
vertebrate host therefore increases with the duration of the blood meal (Piesman et al. 1987, 
Kahl et al. 1998, Zhu 1998, Ohnishi et al. 2001, Crippa et al. 2002). The number of 
spirochetes that reach the tick salivary glands and that infect the host is not 100 % as a 
number of different factors are involved in this process (De Silva and Fikrig 1995, Schwan 
and Piesman 2000). The spirochete load in the tick could influence tick-to-host transmission 
and thus represent a key phenotype of the pathogen life cycle. 
Borrelia afzelii is one of the most common causes of Lyme disease in Europe. The life 
cycle of B. afzelii involves the sheep tick Ixodes ricinus and wild rodent reservoir hosts (Gern 
et al. 1998, Piesman and Gern 2004). After tick-to-host transmission, the spirochetes 
disseminate from the site of the tick bite and establish a widespread, multi-system infection. 
Paper 3 
80 
Pathogen-free ticks that feed on this infected host can acquire the B. afzelii pathogen. An early 
study on B. afzelii found that mouse-to-tick transmission was high over a period of 14 months 
(Gern et al. 1994). In contrast, studies on B. burgdorferi s. s. in wild mice have shown that the 
efficacy of mouse-to-tick transmission can decrease over time for certain strains (Derdakova 
et al. 2004, Hanincova et al. 2008).  
Aging of ticks can affect the persistence and load of the spirochete infection in ticks. 
Previous work on B. burgdorferi s. s. in I. scapularis found that the proportion of infected 
ticks decreased from 74.0% to 15.5% as the spirochete population aged inside the ticks over a 
period of 4 months (Voordouw et al. 2013). A study on B. afzelii in I. ricinus found that the 
spirochete load decreased by 47.2%–86.5% over a period of 6 months depending on the strain 
(Jacquet et al. Submitted-b). Hard ticks, such as I. ricinus, take only one blood meal for each 
of their three stages (Piesman and Gern 2004, Gern 2009) and they do not have access to 
other sources of energy. During the larva-to-nymph molt, there are dramatic changes in the 
tick spirochete load (Piesman et al. 1990). The off-host phase is long (up to a year) (Gern 
2009, Dobson et al. 2011) suggesting that the finite food resources in the tick midgut 
(including the spirochetes) are important for tick survival. Thus nymphal aging may have a 
profound effect on the persistence and load of the spirochete infection inside the nymphal 
tick. 
In this study, we wanted to determine whether the age of infection in the host, the age 
of infection in the tick, and the strain of B. afzelii had an influence on host-to-tick 
transmission and tick spirochete load. In the present study, mice were experimentally infected 
(via tick bite) with two strains of B. afzelii: A3 and A10. To test whether host-to-tick 
transmission of B. afzelii changes over time as the infection ages inside the rodent host, we 
infested the mice with xenodiagnostic larval ticks at 1, 2, 3, and 4 months post-infection. To 
test whether the spirochete load changes over time as the infection ages inside the tick, we 
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allowed the blood-engorged larvae to molt into nymphs and quantified the spirochete load in 
nymphs at 1 and 4 months post-molt. 
 
MATERIALS AND METHODS 
Mice and ticks: Four-week-old, pathogen-free, female Mus musculus Balb/cByJ mice 
(Charles River, l’Arbresle, France) were housed in groups of four or five with ad libitum 
access to food and water (Protector, Switzerland). The animals were allowed to adjust to their 
new surroundings for seven days before the start of the experiment. Mice were housed 
individually following infectious challenge with B. afzelii to avoid any direct transmission 
between animals. The Veterinary Service of the Canton of Neuchâtel, Switzerland, approved 
the animal experimentation protocol used in this study (NE2/2012). Ixodes ricinus ticks came 
from our pathogen-free, laboratory colony that has been maintained for over 33 years at the 
Institute of Biology, University of Neuchâtel. 
Borrelia afzelii ospC strains: Borrelia afzelii ospC strains A3 (isolate E61, GenBank 
accession number: L42890) and A10 (isolate NE4049, GenBank accession number: 
JX103488) were chosen because both strains are highly infectious to mice via tick bite and 
have high systemic (host-to-tick) transmission (85.5% for strain A10 and 53.8% for strain A3) 
(Tonetti et al. 2015). The origins of these strains and their capacity for tick-to-host and 
systemic transmission were described in a previous study (Tonetti et al. 2015).  
Isolates of B. burgdorferi s. l. often contain multiple ospC strains. The purity of the 
two isolates that were used in the present study was tested using 454-sequencing (Tonetti et 
al. 2015). This approach showed that these two isolates were dominated by a single ospC 
strain (Durand et al. Submitted). 
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Immunization trial: The details of this immunization trial were previously described in 
Jacquet et al. (Submitted-b). Briefly, mice were immunized with one of two different rOspC 
proteins: A3 or A10 and subsequently challenged via tick bite with one of two strains of B. 
afzelii: A3 or A10. In what follows, homologous mice were challenged with the strain that 
matched their rOspC antigen whereas heterologous mice were challenged with the strain that 
did not match their rOspC antigen. Control mice were immunized with PBS followed by 
infectious challenge with one of the two strains. The homologous mice were protected by the 
rOspC immunization and did not develop any systemic infection (Jacquet et al. Submitted-b). 
These mice were therefore excluded from the present study. The 23 mice that developed a 
systemic infection belonged to the following groups: 5 control mice infected with strain A3, 5 
control mice infected with strain A10, 5 heterologous mice (immunized with rOspC A10) 
infected with strain A3, and 8 heterologous mice (immunized with rOspC A3) infected with 
strain A10. 
Systemic transmission assay: To measure systemic transmission, mice were infested 
with xenodiagnostic larvae on four separate occasions at 34, 66, 94, and 128 days after the 
nymphal challenge (~1, 2, 3, and 4 months post-infection). Hereafter these infestations will be 
referred to as mouse age of infection 1, 2, 3, and 4 months. For each of the four infestations, 
50 to 100 larvae were placed on the head of each mouse. Mice were anesthetized with a mix 
of xylazine, ketamine and PBS (1:2:9; 5 µl per gram of mouse) during this procedure. Infested 
mice were placed in individual cages that facilitated the collection of blood-engorged larval 
ticks. Blood-engorged larvae were placed in individual tubes, containing a piece of moistened 
paper towel, and were allowed to molt into nymphs. These tubes were placed in plastic 
cryoboxes that were stored at room temperature in closed plastic storage boxes that contained 
2 cm of water to maintain high humidity and avoid dehydration of ticks. For mouse age of 
infection 2, 3, and 4 months, the nymphs were frozen at -20°C at 1, 2, 3, and 4 months after 
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molting into the nymphal stage. For mouse age of infection 1 month, nymphs were frozen at -
20°C at 1 month post-molt and the remaining nymphs were used for other experiments. For 
each of the 13 combinations of mouse age of infection and nymphal age, a maximum of 10 
nymphs were frozen. 
DNA extraction: In the present study, only the nymphs aged 1 and 4 months were 
processed. For each of the six combinations of mouse age of infection (2, 3, and 4 months) 
and nymphal age (1 and 4 months), DNA was extracted from a maximum of 10 nymphs. For 
mouse age of infection 1 month, there were only 1-month-old nymphs and no 4-month-old 
nymphs. A total of 1,610 nymphs were processed during the experiment (7 combinations*23 
mice/combination*10 nymphs/mouse). Total DNA was extracted using a TissueLyser II and 
DNeasy 96 Blood & Tissue kit well plates (QIAGEN). The DNA extraction protocol was 
described in a previous study (Jacquet et al. Submitted-b). 
qPCR to determine spirochete infection: A quantitative PCR amplifying a fragment of 
the flagellin gene (Schwaiger et al. 2001) was used to detect and quantify Borrelia DNA. The 
qPCR protocol was described in a previous study (Jacquet et al. Submitted-b). 
 
STATISTICAL ANALYSES 
All statistical analyses were done in R version 3.1.0. (R Development Core Team 
2009). 
Definition of B. afzelii infection status for ticks: Ticks were considered infected if at 
least two of the three runs of the qPCR assay tested positive for B. afzelii, as described in a 
previous study (Jacquet et al. Submitted-b). 
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Spirochete loads of xenodiagnostic ticks infected via systemic transmission: The 
spirochete load of each tick was calculated as the geometric mean of the three replicate runs 
(negative runs were excluded). Similarly, the average tick spirochete load for each mouse was 
calculated as the geometric mean of the infected ticks (negative ticks were excluded). 
Effect of mouse age of infection, strain, and immunization treatment on the systemic 
transmission rate of B. afzelii: The systemic (or host-to-tick) transmission rate of each mouse 
was measured as the proportion of nymphs that tested positive for B. afzelii using the qPCR 
assay. We conducted separate analyses for each nymphal age: 1 and 4 months. A generalized 
linear model (GLM) with binomial errors was used to model the mouse-specific systemic 
transmission rate as a function of three fixed factors: the mouse age of infection (1, 2, 3 and 4 
months), strain (two levels: A3 and A10), immunization treatment (two levels: control and 
heterologous), and their interactions.  
Effect of mouse age of infection, strain, and immunization treatment on the spirochete 
load of infected nymphs: For the subset of infected nymphs (i.e. uninfected nymphs were 
excluded), a linear mixed effects model with normal errors was used to model the log-
transformed spirochete load as a function of the mouse age of infection, strain, immunization 
treatment, and their interactions. The identity of the mouse was included as a random factor. 
The analyses were conducted separately for the 1-month-old nymphs and the 4-month-old 
nymphs. 
Effect of nymphal age, strain, and immunization treatment on the probability of 
detecting the B. afzelii infection in nymphal ticks: Nymphal ageing may influence the 
nymphal spirochete load and hence the probability of detecting the B. afzelii infection in the 
nymphal ticks. The probability of detecting spirochete infection in the nymphal ticks was 
defined as the proportion of nymphs infected with B. afzelii. Nymphal age represents paired 
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data because for each larval infestation, the blood-engorged larvae were split into two groups 
that were killed at either 1 month or 4 months after the larva-to-nymph molt.  
The ticks from the first larval infestation (1 month after the infectious challenge) were 
excluded from the analysis because this group did not have any four-month-old nymphs. A 
generalized linear model (GLM) with binomial errors was used to model the probability that a 
nymph was infected with B. afzelii as a function of nymphal age (1 or 4 months), strain (A3 or 
A10), immunization treatment (control or heterologous), and their interactions. The mouse 
age of infection was either ignored or the analyses were conducted separately for each mouse 
age of infection (2, 3, and 4 months). 
Effect of nymphal age, strain, and immunization treatment on the spirochete load of 
infected nymphs: The ticks from the first larval infestation (1 month after the infectious 
challenge) were excluded from the analysis because this group did not have any four-month-
old nymphs. A linear mixed effects model (GLM) with normal errors was used to model the 
log-transformed spirochete load as a function of nymphal age (1 or 4 months), strain (A3 or 
A10), immunization treatment (control or heterologous), and their interactions. The mouse 
age of infection was either ignored or the analyses were conducted separately for each mouse 
age of infection (2, 3, and 4 months). 
 
RESULTS: 
All means are reported with their standard errors unless otherwise indicated. 
Effect of mouse infection age on the systemic transmission rate: For the 1-month old 
nymphs, the systemic transmission rate was highest at 1 month post-infection and then 
decreased but remained stable for the next three months (Table 1). For the 1-month-old 
nymphs, there was a significant interaction between mouse age of infection and strain on the 
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systemic transmission rate (Δ 2 = 10.78, Δ df =3, p=0.013). We therefore analyzed the effect 
of the mouse age of infection on the systemic transmission rate separately for each strain. The 
mouse age of infection had a significant effect on the systemic transmission rate for strain A3 
(Δ 2 = 7.87, Δ df = 3, p = 0.049) and strain A10 (Δ 2 = 41.8, Δ df = 3, p < 0.001). For strain 
A3, a Tukey HSD test found that the systemic transmission rate at month 1 was significantly 
higher than month 2 (p = 0.037) but not months 3 and 4. For strain A10, a Tukey HSD test 
found that the systemic transmission rate at month 1 was significantly higher than months 2, 
3, and 4 (p <0.001 for all three contrasts). For the 4-month-old nymphs, there was no 
significant effect of the mouse age of infection on the systemic transmission rate.  
Effect of the mouse age of infection on the spirochete load of infected nymphs: For the 
1-month-old nymphs, the effect of the 3-way interaction (mouse age of infection, strain, 
immunization treatment) on the nymphal spirochete load was almost significant (Δ 2 = 7.36, 
Δ df = 3, p = 0.0613). The 2-way interaction between mouse age of infection and 
immunization treatment had a significant effect on the nymphal spirochete load (Δ 2 = 15.63, 
Δ df = 3, p = 0.0014). The effect of the mouse age of infection on the nymphal spirochete load 
was therefore analyzed separately for each immunization treatment (control and 
heterologous). For the ticks fed on control mice (Figure 1), there was a significant effect of 
the 2-way interaction between mouse age of infection and strain (Δ 2 = 9.66, Δ df = 3, p = 
0.022). For the control mice infected with strain A3, there was no effect of the mouse age of 
infection on the nymphal spirochete load (Δ 2 = 4.78, Δ df = 3, p = 0.188). In contrast, for the 
control mice infected with strain A10, the nymphal spirochete load appeared to cycle with the 
mouse age of infection (Δ 2 = 22.63, Δ df = 3, p < 0.001). A Tukey HSD post-hoc test found 
a cyclical pattern in the nymphal spirochete load: month 1 > month 2 (p = 0.0347), month 2 < 
month 3 (p < 0.001), and month 3 > month 4 (p < 0.001). For the 1-month-old nymphs fed on 
the heterologous mice (Figure 1), there was a significant effect of strain (Δ 2 = 6.659, Δ df = 
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1, p = 0.010). The nymphal spirochete load was consistently higher for strain A10 than strain 
A3 (Figure 1). We also split the dataset with respect to the mouse age of infection and found 
that the effect of the immunization treatment was only significant when the infection inside 
the mice was 1 month old (Δ 2 = 8.24, Δ df = 1, p = 0.004).  
For the 4-month old nymphs, there was no effect of mouse age of infection (2, 3, or 4 
months), strain (A3 or A10), or the immunization treatment (control or heterologous) on the 
nymphal spirochete load. 
Effect of nymphal age on the probability of detecting the B. afzelii infection in 
nymphal ticks: The analyses were done separately for each mouse age of infection (2, 3, and 4 
months). There was no effect of nymphal age, strain, immunization treatment, and their 
interactions on the probability of detecting the B. afzelii infection in the nymphal ticks (p > 
0.050). 
Effect of nymphal age on the spirochete load of infected nymphs: There were no 
significant interactions between nymphal age, immunization treatment, and strain on the 
nymphal spirochete load. There was a significant effect of strain (Δ 2 = 12.35, Δ df = 1, p < 
0.001): nymphs infected with strain A10 had a spirochete load that was 2.2 times higher than 
nymphs infected with strain A3. There was also a significant effect of nymphal age (Δ 2 = 
194.25, Δ df = 1, p < 0.001): 1-month-old nymphs had a mean spirochete load that was 9.2 
times higher than 4-month-old nymphs.  
 
DISCUSSION: 
The efficiency of systemic (host-to-tick) transmission depends on the age of the 
infection inside the rodent host and on the strain of Borrelia afzelii. Systemic transmission 
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was highest when the infection inside the mouse was 1 month old, and was lower but stable 
for the remaining three months. Nymphal age had an important effect on the spirochete load 
inside the nymphal tick. The spirochete load decreased 9.2-fold as the infection aged inside 
the nymphs over a period of three months. 
The duration of host-to-tick transmission is a critical determinant of the reproductive 
number and the epidemiology of vector-borne pathogens. For example, TBEV has a short 
duration of host-to-tick transmission and a reproductive number that is an order of magnitude 
lower compared to Borrelia pathogens (Randolph et al. 1996, Hartemink et al. 2008, Harrison 
et al. 2011, Harrison and Bennett 2012). Early studies on B. burgdorferi s. l. suggested that 
mice had high systemic transmission over the duration of their infection (Donahue et al. 1987, 
Gern et al. 1994). Subsequent theoretical models used this paradigm of long-lasting high 
systemic transmission (50.0% for ~120 days) to show that B. burgdorferi s. l. pathogens have 
a high reproductive number (Hartemink et al. 2008, Harrison et al. 2011, Harrison and 
Bennett 2012). Later studies on B. burgdorferi s. s. found that mouse-to-tick transmission can 
decrease dramatically over short periods of time (Lindsay et al. 1997) and can differ 
dramatically between strains (Derdakova et al. 2004, Hanincova et al. 2008). For example, 
mouse-to-tick transmission declines from 83.3% to 4.1% over a period of 30 days for strain 
B348 whereas it remains high for strain BL206 (Derdakova et al. 2004). Subsequent modeling 
efforts showed that natural selection can maintain a diversity of strains with different age-of-
infection-related patterns in host-to-tick transmission (Haven et al. 2012). 
Kurtenbach et al. (2006) suggested that some Borrelia genospecies use a “boom-and-
bust” strategy to transmit more efficiently to new larval ticks. This strategy allows the 
spirochetes to achieve high host-to-tick transmission in a short period of time. After the early 
“boom” of host-to-tick transmission, the Borrelia infection is cleared by the host immune 
system. The empirical studies by Derdakova et al. (2004) and Hanincova et al. (2008) on B. 
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burgdorferi s. s. and the modeling study by Haven et al. (2012) suggest that there was such a 
trade-off between ‘fast’ and ‘slow’ strains. In contrast, the present study and our previous 
work have found no evidence of such a trade-off between very early (co-feeding) transmission 
and later (systemic) transmission in B. afzelii (Tonetti et al. 2015, Jacquet et al. Submitted-a).  
Studies on strain-specific differences in the relationship between the age of infection 
and host-to-tick transmission are non-existent for B. afzelii. Previous studies have either 
ignored the effect of strain (Gern et al. 1994, Humair et al. 1999) or have compared host-to-
tick transmission between strains at a single age of infection (Tonetti et al. 2015, Jacquet et al. 
Submitted-a). The present study shows that for two common strains of B. afzelii, there is high 
systemic transmission over the epidemiologically relevant lifespan of the infection inside the 
rodent host. For both strains, the systemic transmission rate was highest in ticks that acquired 
spirochetes when the infection was 1 month old in the mouse. Strain A10 had higher systemic 
transmission than strain A3 as shown in our previous work (Tonetti et al. 2015, Jacquet et al. 
Submitted-b).  
For the control mice infected with strain A10, the nymphal spirochete load fluctuated 
over the four infestations suggesting the presence of a cyclical immune phenomenon. During 
host infection, Borrelia spirochetes are able to up- or down-regulate surface proteins, or to 
modify certain surface proteins involved in the infection of the host such as the VlsE protein 
(Wilske et al. 1988, Ohnishi et al. 2001, Ohnishi et al. 2003, Crother et al. 2004, Connolly and 
Benach 2005, Graves et al. 2013, Tilly et al. 2013). This immune evasion strategy could cause 
pathogen abundance in the vertebrate host and host-to-vector transmission to fluctuate as has 
been observed for the malaria pathogen Plasmodium falciparum (Zhang and Norris 1998, 
Craig and Scherf 2001). Future studies should investigate whether this cyclical phenomenon 
occurs in other strains and whether it lasts for more than 4 months. 
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Our study suggests that the host immune system plays an important role in the host-to-
tick transmission of B. afzelii (Figure 1). In a previous study, we showed that the spirochete 
load in the nymphs that had fed on the heterologous mice was half that of the nymphs that had 
fed on the control mice (Jacquet et al. Submitted-b). We interpreted this cross-immunity effect 
on the nymphal spirochete load as evidence that previous immune experience with the 
‘wrong’ OspC antigen allowed the heterologous mice to develop a faster and more effective 
antibody response against the spirochete infection than the control mice (Jacquet et al. 
Submitted-b). However, there was no such cross-immunity effect on the spirochete load for 
infestations 2, 3, and 4. This result is expected because 2 months post-infection is enough 
time for the control mice to develop an equally efficient Borrelia-specific antibody response. 
In summary, we observed a transient cross-immunity effect on the nymphal spirochete load 
that disappeared over time as the acquired immune systems of the control mice caught up with 
those of the heterologous mice. 
Few studies have investigated the dynamics of the spirochete load over long periods of 
time in infected ticks. Most studies have investigated changes in the spirochete population 
over the duration of the tick bite (De Silva and Fikrig 1995, Zhu 1998, Piesman et al. 2001), 
or the duration of the larva-to-nymph molting period (Piesman et al. 1990). Here, we analyzed 
the effect of nymphal age on the spirochete load over a longer period of time. Nymphs killed 
at one month after the molt had a spirochete load that was 6.3 to 15.3-fold lower than nymphs 
killed at four months after the molt. This effect of nymphal ageing on the spirochete load 
could influence the future infectiousness of the ticks because the host immune system is more 
likely to eliminate a small dose of pathogen cells (Schmid-Hempel 2008).  
Temperature and relative humidity influence the rate at which ticks consume their 
energetic resources (Randolph and Storey 1999, Herrmann and Gern 2012). In this study, 
ticks were kept at room temperature and high humidity. In the field, by contrast, ticks 
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frequently encounter dehydrating conditions that threaten their water balance and survival 
(Gern 2009). Further studies should investigate whether natural fluctuations in temperature 
and relative humidity affect the tick spirochete load. The questing behavior of I. ricinus 
consumes the food resources present in the midgut (which may include the spirochetes). The 
energetic resources available to the tick and the spirochete population are limited by the 
amount of blood ingested by the tick during the previous stage. Unlike mosquito vectors that 
feed on flower nectar, ticks obtain all of their energy resources from the blood meal. Thus the 
tick and the spirochete population are faced with an ever-diminishing supply of energetic 
resources as the two age over time. 
 
CONCLUSIONS: 
Future studies should test whether Ixodes ticks can lose their Borrelia infections under natural 
and stressful conditions. The infectiousness of young and older nymphs could be compared to 
test whether nymphal aging influences the probability of tick-to-host transmission. 
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6. Generâl discussion 
This PhD thesis, based on one main experiment, allowed us to test a variety of 
hypotheses of how the rodent immune system interacts with the Lyme disease pathogen B. 
afzelii. In particular, this work addresses three main subjects: (1) the effects of acquired 
immunity in the vertebrate host on the transmission of B. afzelii, (2) the difference in 
transmission phenotypes between genetically different B. afzelii strains, and (3) the 
maintenance of the pathogen in the vertebrate host and the tick vector.  
Immunization with the rOspC antigen protected mice from infection with the matching 
homologous ospC strain. Previous studies on B. afzelii and B. burgdorferi s. s. had shown that 
immunization with rOspC protects mice from infectious challenge with strains carrying the 
same ospC allele (Preac-Mursic et al., 1992; Probert and Lefebvre, 1994; Gilmore et al., 1996; 
Scheiblhofer et al., 2003). However, studies investigating cross-protection to strains carrying 
different ospC alleles are relatively rare (Probert et al. 1997) and have not been conducted in 
B. afzelii. We found that there was limited cross-protection of the OspC-specific antibody 
response. Mice immunized with rOspC A3 were not completely protected from infectious 
challenge with strain A10 and vice versa. The highly variable OspC antigen thus allows 
Borrelia ospC strains to super-infect mice that have previous immune experience with other 
OspC antigens. Evidence that the OspC-specific antibody does not cross-protect rodents 
against other ospC strains in the field comes from the observation that wild rodents are 
frequently infected with multiple ospC strains (Brisson and Dykhuizen, 2004; Anderson and 
Norris, 2006; Pérez et al., 2011; Andersson et al., 2013). In the present study, we used 
immunization with the OspC antigen to test whether acquired immunity and cross-immunity 
influenced other aspects of the epidemiology of B. afzelii.  
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Acquired immunity in laboratory rodents reduced the efficacy of co-feeding 
transmission of B. afzelii. For strain A10, immunizing mice with rOspC A10 reduced the 
efficacy of co-feeding by 15-fold (from 51.6 % to 3.3 %). Co-feeding transmission was not 
completely blocked on OspC-immunized rodents. Five mice protected from systemic 
infection still produced some infected ticks via co-feeding. However, the co-feeding 
transmission rate on these mice was so low (1.8% and 3.3% for strains A3 and A10, 
respectively) that this strategy is unlikely to make a significant contribution to pathogen 
fitness (Hartemink et al., 2008). Thus our prediction that B. afzelii uses co-feeding 
transmission to evade acquired immunity in the vertebrate host was not supported, as the 
OspC-specific antibody response blocked 93.6 % of the co-feeding transmission of strain 
A10. Studies on other tick-borne pathogens have also shown that acquired immunity reduces 
co-feeding transmission but there is much variation in the magnitude of the effect size (Jones 
and Nuttall, 1989; Labuda et al., 1997b; Levin and Fish, 2000).  
We found some cross-protective acquired immunity between the two strains of B. 
afzelii. Of the mice immunized with rOspC A10, 28.6% (2/7) were protected from the 
infectious challenge with strain A3. In contrast, immunization with rOspC A3 did not protect 
mice against strain A10. This asymmetric cross-immunity gives the dominant strain a two-
fold competitive advantage over the weaker strain (Read and Taylor, 2001; Frank, 2002). 
First, the dominant strain induces an antibody response that blocks the weaker strain from 
super-infecting the same host. Second, the dominant strain is not affected by cross-immunity 
and can therefore super-infect hosts carrying the weaker strain. A recent field study found that 
A10 was one of the more common ospC strains in populations of I. ricinus at two different 
sites in Switzerland (Pérez et al., 2011; Tonetti et al., 2015). One potential explanation for the 
high frequency of strain A10 is the asymmetric cross-immunity advantage observed in the 
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present study. Another explanation is that strain A10 has high fitness in rodent hosts 
compared to other strains of B. afzelii (Tonetti et al., 2015).  
The present study also allows us to speculate on the mechanism by which OspC-
specific antibodies protect mice against infection with B. afzelii. The immunization treatment 
did not influence the prevalence of infection or the spirochete load in the blood-engorged 
challenge nymphs. This observation suggests that OspC-specific antibodies are not 
borreliacidal, as previously demonstrated by Gilmore et al. (1996). The OspC-specific 
antibodies could block migration of the spirochetes from the tick midgut to the tick salivary 
glands (Gilmore and Piesman, 2000), or kill the spirochetes at the site of the tick bite. These 
two hypotheses are not mutually exclusive (Ohnishi et al., 2001). Moreover, tick saliva 
contains a number of substances that suppress and modulate the host immune response 
(Wikel, 1999; Kuthejlova et al., 2001; Kotál et al., 2015). The feeding lesion of the tick in the 
skin of the vertebrate host represents an immuno-suppressed area that facilitates growth and 
replication of the local spirochete population. However, modulation of host immunity by tick 
saliva was not sufficient to evade the OspC-specific antibodies that ultimately blocked co-
feeding transmission.  
To test the effect of cross-immunity on the transmission of B. afzelii, we compared the 
heterologous group (mice immunized with the wrong OspC antigen) with the control group 
(mice that were completely immunologically naive). Cross-immunity had no effect on the rate 
of systemic transmission or on the rate of co-feeding transmission. However, we found a 
significant effect of cross-immunity on the tick spirochete load. Previous immune experience 
with the wrong OspC antigen allowed the heterologous mice to produce a more effective 
antibody response against the B. afzelii infection. This cross-immunity advantage 
subsequently reduced the spirochete load in the ticks that fed on the heterologous mice. 
Borrelia pathogens down-regulate the expression of the OspC antigen about two weeks after 
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they have established a systemic infection in the host (Zhong et al., 1997; Crother et al., 2004; 
Liang et al., 2004). OspC-specific antibodies are therefore not expected to influence host-to-
tick transmission. However, the control of gene expression is not 100% perfect (Gilmore and 
Piesman, 2000; Ohnishi et al., 2001) and OspC-specific antibodies could clear any spirochetes 
that accidentally expressed the OspC antigen in the rodent host or the tick vector. We found 
no effect of cross-immunity on the spirochete load in the mouse tissues. Thus the observed 
cross-immunity effect on the tick spirochete load probably occurred after the host-to-tick 
transmission event. Perhaps the OspC-specific antibodies in combination with other 
components of the vertebrate immune system (e.g. the complement system or phagocytic 
cells) killed some of the spirochetes inside the midgut of the larval tick during the blood meal. 
A recent study found that the innate immune response of the vertebrate host plays an 
important role in structuring the spirochete load inside I. ricinus nymphs (Herrmann et al., 
2013). In the present study, we showed that cross-reactive acquired immunity can also 
influence spirochete load inside I. ricinus nymphs. The 2-fold reduction in spirochete load 
observed in the present study could have important consequences for spirochete fitness.  
In contrast to the cross-immunity effect on the spirochete load of ticks infected via 
systemic transmission, we found no effect of cross-immunity on the spirochete load in ticks 
infected via co-feeding transmission. We interpret this result as evidence that co-feeding 
transmission allowed B. afzelii to evade the negative effects of the cross-immunity. Previous 
immune experience with the ‘wrong’ OspC antigen allowed the heterologous mice to develop 
a more effective antibody response against the B. afzelii infection compared to the control 
mice. However, this infection-specific antibody response would have taken two or more 
weeks to develop. Co-feeding occurred during the five days following the infectious challenge 
and so there was not enough time for the infection-specific antibody response to interfere with 
co-feeding transmission. In contrast, the mice were infested with the second batch of larval 
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ticks at four weeks after the infectious challenge at which point in time the infection-specific 
antibody response was highly developed and capable of interfering with systemic 
transmission. Thus the instantaneous nature of co-feeding relative to the infectious challenge 
allowed this mode of transmission to evade the time-lagged, negative effects of cross-
immunity. 
The capacity of B. afzelii to infect the vertebrate host is probably related to the number 
of spirochetes that are transmitted during the infected tick bite (Schmid-Hempel, 2008). The 
present study showed that there are many factors that can influence the spirochete load inside 
the nymphal tick. The mode of transmission had an important effect on the spirochete load in 
nymphs infected as larvae. The spirochete load was up to six times lower in nymphs infected 
as larvae via co-feeding than in nymphs infected as larvae via systemic transmission. The 
strain of B. afzelii also affected the nymphal spirochete load, as it was lower for strain A3 than 
A10. The higher spirochete load of strain A10 in the tick vector may be another explanation 
as to why this strain is so common in different locations in Europe (Pérez et al., 2011; 
Andersson et al., 2013). The age of the infection in the vertebrate host also created variation 
in the nymphal spirochete load.  
The age at which the nymphal tick was killed also influenced the spirochete load 
detected in the nymphal ticks. The spirochete load in nymphs killed four months after the 
larva-to-nymph molt was 10 times lower than that of nymphs killed one month after the molt, 
even though both of these nymphs had fed as larvae on the same mice at the same time. This 
result suggests that the spirochete population inside the nymph declines over time following 
the larva-to-nymph molt. 
OspC is a critical pathogen virulence factor for host infection (Pal et al., 2004a; 
Stewart et al., 2006; Fingerle et al., 2007; Radolf and Caimano, 2008; Tilly et al., 2009; 
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Seemanapalli et al., 2010; Tilly et al., 2013). Borrelia spirochetes express the OspC antigen in 
the midgut of the tick, at the site of the tick bite, and during dissemination inside the 
vertebrate host. The temporal pattern of expression makes the OspC antigen an accessible 
target for the immune system of the vertebrate host. The present study showed that the OspC-
specific antibody response is efficient at blocking both co-feeding and systemic transmission. 
Selection by the vertebrate immune system has resulted in the diversification of the ospC gene 
to facilitate super-infection of the vertebrate host.  
Fast development of a systemic infection in the vertebrate host will lead to earlier 
transmission to naïve larval ticks that feed on that host. The persistence of the systemic 
infection in the vertebrate host is important for maintaining high levels of host-to-tick 
transmission over the duration of the transmission season of Lyme disease. The number of 
spirochetes acquired by the larval tick may be important because the larval tick will encounter 
many metabolic changes during its molt into the nymphal stage. A small number of 
spirochetes acquired by the tick at the larval stage could result in a lower number of 
spirochetes transmitted during the nymphal blood meal. The present study showed that 
nymphal aging reduces the tick spirochete load over time.  
The spirochete load was lower in ticks infected via co-feeding compared to ticks 
infected via systemic transmission. Previous studies have investigated the dynamics of the 
spirochete population inside the tick vector over a short time period (molting phase or the 
weeks post-challenge). Future studies should investigate whether the nymphal spirochete load 
and the mode of transmission by which the spirochete infection was acquired influence tick-
to-host transmission. 
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In summary, this PhD thesis provides new information on the host-parasite 
interactions of an important Lyme disease pathogen, on the effect of acquired immunity in the 
vertebrate host on pathogen transmission, and on the mechanism of co-feeding transmission.  
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